Organometallic compound and organic light-emitting device including the same
The introduction of a specific organometallic compound with enhanced electrical properties and thermal stability addresses the limitations of existing compounds, improving the performance of organic light-emitting devices in terms of driving voltage, current density, efficiency, power, and lifetime.
Patent Information
- Application Number
- JP2023070583
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-08-10
- Filing Date
- 2023-04-24
- Publication Date
- 2024-12-04
- Estimated Expiration
- 2036-08-16
AI Technical Summary
Existing organic light-emitting devices face challenges in improving the electrical properties and thermal stability of organometallic compounds used in them.
The development of an organometallic compound represented by a specific chemical formula, which includes transition metals and various organic groups, enhances the electrical properties and thermal stability of the organic layer in the device.
The organometallic compound improves driving voltage, current density, efficiency, power, color purity, and lifetime of the organic light-emitting device.
Smart Images

Figure 0007594622000113 
Figure 0007594622000001 
Figure 0007594622000002
Abstract
Description
[Technical field]
[0001] The present invention relates to an organometallic compound and an organic light emitting device including the same, and more particularly to an organometallic compound having excellent electrical properties and thermal stability and an organic light emitting device including the same. [Background technology]
[0002] An organic light emitting device is a self-emitting device that has advantages such as a wide viewing angle, excellent contrast, a short response time, excellent brightness, driving voltage and response speed characteristics, and the ability to be multi-colored.
[0003] According to one example, an organic light emitting device includes an anode, a cathode, and an organic layer interposed between the anode and the cathode, the organic layer including a light emitting layer. A hole transport region is provided between the anode and the light emitting layer, and an electron transport region is provided between the light emitting layer and the cathode. Holes injected from the anode travel to the light-emitting layer via the hole transport region, and electrons injected from the cathode travel to the light-emitting layer via the electron transport region. The holes and electrons recombine in the light-emitting layer region to form excitons. Light is produced as the excitons change from the excited state to the ground state.
[0004] However, further improvement in electrical properties and thermal stability of organometallic compounds used in organic light-emitting devices remains an issue. Summary of the Invention [Problem to be solved by the invention]
[0005] The present invention has been made in consideration of the above-mentioned problems with conventional organic light-emitting devices, and an object of the present invention is to provide an organometallic compound and an organic light-emitting device containing the same. [Means for solving the problem]
[0006] The organometallic compound according to the present invention, which has been made to achieve the above object, is characterized by being represented by the following chemical formula 1. [ka] In the above Chemical Formula 1, M is selected from the group consisting of first-period transition metals, second-period transition metals, and third-period transition metals; A 1 ~A 4 are independent of each other, C 5 -C 20 Carbocyclic groups and C 1 -C 20 heterocyclic groups, X 1 ~X 4 are each independently selected from carbon atoms (C) and nitrogen atoms (N); 3 and X 4 At least one of is N, B 1 ~B 4 are each independently selected from a single bond, O and S; Y 1 ~Y 3 are each independently selected from a single bond and a divalent linking group, 1 ~Y 3 At least one of the groups is a divalent linking group, Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-1) to (2-4), [ka] In the chemical formulas (2-1) to (2-4), Y 21 and Y 22 are each independently a substituted or unsubstituted C 1 -C 10 Alkylene groups and substituted or unsubstituted C 2-C 10 alkenylene groups, a21 and a22 are independently selected from the group consisting of 0, 1, 2, 3, 4, and 5; R 21 ~R 27 are each independently hydrogen, deuterium, substituted or unsubstituted C 1 -C 60 Alkyl groups, substituted or unsubstituted C 2 -C 60 Alkenyl groups, substituted or unsubstituted C 2 -C 60 Alkynyl groups, substituted or unsubstituted C 1 -C 60 Alkoxy groups, substituted or unsubstituted C 3 -C 10 Cycloalkyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkyl groups, substituted or unsubstituted C 3 -C 10 Cycloalkenyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl groups, substituted or unsubstituted C 6 -C 60 Aryl groups, substituted or unsubstituted C 6 -C 60 Aryloxy groups, substituted or unsubstituted C 6 -C 60 Arylthio groups, substituted or unsubstituted C 7 -C 60 Arylalkyl groups, substituted or unsubstituted C 1 -C 60 Heteroaryl groups, substituted or unsubstituted C 1 -C 60 Heteroaryloxy groups, substituted or unsubstituted C 1 -C 60 Heteroarylthio groups, substituted or unsubstituted C 2 -C 60 is selected from the group consisting of heteroarylalkyl groups, substituted or unsubstituted monovalent non-aromatic fused polycyclic groups, and substituted or unsubstituted monovalent non-aromatic fused polycyclic heterocyclic groups; d1 and d2 are independently selected from 0, 1, 2, 3, and 4; If d1 is 2 or more, multiple Z 1 may be the same or different, and if d2 is 2 or more, a plurality of Z 2 may be the same or different from each other, X 3 If N, then d 1 is selected from 1, 2, 3 and 4, or X 4 If is N, then d2 is selected from 1, 2, 3, and 4; R 1 ~R 4 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 Alkyl groups, substituted or unsubstituted C 2 -C 60 Alkenyl groups, substituted or unsubstituted C 2 -C 60 Alkynyl groups, substituted or unsubstituted C 1 -C 60 Alkoxy groups, substituted or unsubstituted C 3 -C 10 Cycloalkyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkyl groups, substituted or unsubstituted C 3 -C 10 Cycloalkenyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl groups, substituted or unsubstituted C 6 -C 60 Aryl groups, substituted or unsubstituted C 6 -C 60 Aryloxy groups, substituted or unsubstituted C 6 -C 60 Arylthio groups, substituted or unsubstituted C 7 -C 60Arylalkyl groups, substituted or unsubstituted C 1 -C 60 Heteroaryl groups, substituted or unsubstituted C 1 -C 60 Heteroaryloxy groups, substituted or unsubstituted C 1 -C 60 Heteroarylthio groups, substituted or unsubstituted C 2 -C 60 Heteroarylalkyl groups, substituted or unsubstituted monovalent non-aromatic condensed polycyclic groups, substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic groups, -C(=O)(Q 7 ), and -N(Q 7 )(Q 8 ), and R 1 and R 4 , or R 2 and R 3 can optionally be linked together to form a saturated or unsaturated ring; Q 7 and Q 8 are independent of each other, C 1 -C 60 Alkyl group and C 6 -C 60 aryl groups, b1 to b4 are each independently selected from 1, 2, 3, and 4; L 1 is selected from monodentate and bidentate ligands; a1 is selected from 0, 1 and 2; * indicates a bonding site with an adjacent atom.
[0007] The organic light-emitting device according to the present invention, which has been made to achieve the above object, is characterized by having a first electrode, a second electrode, and an organic layer interposed between the first electrode and the second electrode, which includes a light-emitting layer and contains at least one organometallic compound represented by Chemical Formula 1. Effect of the Invention
[0008] According to the organometallic compound and the organic light emitting device including the same according to the present invention, since it contains at least one organometallic compound represented by Chemical Formula 1, the organic layer has excellent electrical properties and thermal stability, and the organic light emitting device using this organometallic compound has excellent driving voltage, current density, efficiency, power, color purity, and life properties. [Brief description of the drawings]
[0009] [Figure 1] 1 is a cross-sectional view illustrating a schematic structure of an organic light-emitting device according to an embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0010] Next, specific examples of embodiments for carrying out the organometallic compound and the organic light-emitting device including the same according to the present invention will be described with reference to the drawings.
[0011] The advantages, features, and methods of achieving the present invention will become apparent from the following detailed description of the preferred embodiments with reference to the accompanying drawings. However, the present invention is not limited to the following embodiments and may be embodied in various forms. Hereinafter, an embodiment of the present invention will be described in detail with reference to the attached drawings. When describing with reference to the drawings, the same or corresponding components are given the same reference numerals and duplicate descriptions thereof will be omitted. In the following embodiments (examples), the singular expression includes the plural expression unless the context clearly indicates otherwise. In the following embodiments (examples), terms such as "comprise" or "have" mean that the features or components described in the specification are present, and do not preclude the possibility that one or more other features or components may be added. In the following embodiments (examples), when a part such as a film, region, or component is said to be on or above another part, this does not only include the case where it is directly on top of the other part, but also the case where another film, region, component, etc. is interposed between them. In the drawings, the size of components may be exaggerated or reduced for the convenience of explanation. For example, the size and thickness of each component shown in the drawings are arbitrarily shown for the convenience of explanation, and the present invention is not necessarily limited to what is shown in the drawings. In this specification, the term "organic layer" refers to any single and / or multiple layers interposed between a first electrode and a second electrode in an organic light-emitting device. The material contained in the "organic layer" is not limited to an organic material.
[0012] The organometallic compound according to one embodiment of the present invention is represented by Chemical Formula 1 shown below. [ka] In Chemical Formula 1, M is selected from the group consisting of first-row transition metals, second-row transition metals, and third-row transition metals. For example, in Formula 1, M is selected from the group consisting of iridium (Ir), platinum (Pt), osmium (Os), ruthenium (Ru), rhodium (Rh), palladium (Pd), copper (Cu), silver (Ag), gold (Au), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), and thulium (Tm), but is not limited thereto. As another example, in Formula 1, M may be selected from the group consisting of Ir, Pt, Os, Ti, Zr, Hf, Eu, Tb, and Tm, but is not limited thereto. As yet another example, in Formula 1, M is selected from the group consisting of Ir, Pt, and Os, but is not limited thereto. As yet another example, in Formula 1, M can be Pt, but is not limited thereto.
[0013] In Chemical Formula 1, A 1 ~A4 are independent of each other, C 5 -C 20 Carbocyclic groups and C 1 -C 20 It is also selected from heterocyclic groups. For example, in Chemical Formula 1, A 1 ~A 4 are independent of each other, C 5 -C 20 Carbocyclic groups and C 1 -C 20 heterocyclic groups, A 3 and A 4 At least one of them is C 1 -C 20 It can also be selected from heterocyclic groups, but is not limited thereto. As another example, in Chemical Formula 1, A 1 ~A 4 are each independently selected from a benzene group, a naphthalene group, a pyrrole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a triazole group, an indazole group, a tetrahydroindazole group, a pyridine group, a thiazine group, an oxazine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a naphthyridine group, an indole group, a benzimidazole group, a benzothiazole group, a benzisothiazole group, a benzoxazole group, a benzisoxazole group, a benzothiazine group, a benzoxazine group, a dibenzofuran group, and a dibenzothiophene group; A 3 and A 4At least one of the groups may be selected from the group consisting of a pyrrole group, an imidazole group, a pyrazole group, a thiazole group, an isothiazole group, an oxazole group, an isoxazole group, a triazole group, an indazole group, a tetrahydroindazole group, a pyridine group, a thiazine group, an oxazine group, a pyrimidine group, a pyrazine group, a pyridazine group, a triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a naphthyridine group, an indole group, a benzimidazole group, a benzothiazole group, a benzoisothiazole group, a benzoxazole group, a benzoisoxazole group, a benzothiazine group, and a benzoxazine group, but is not limited thereto.
[0014] As yet another example, in Chemical Formula 1, A 1 ~A 4 are also selected independently from among a benzene group, a naphthalene group, a pyrazole group, an indazole group, a tetrahydroindazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a quinoline group, an isoquinoline group, an indole group, a benzimidazole group, a dibenzofuran group and a dibenzothiophene group, A 3 and A 4 At least one of the groups may be selected from the group consisting of a pyrazole group, an indazole group, a tetrahydroindazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a quinoline group, an isoquinoline group, an indole group, and a benzimidazole group, but is not limited thereto. As yet another example, in Formula 1, A 1 ~A 4 are each independently selected from the group consisting of a benzene group, a naphthalene group, a pyrazole group, an indazole group, a tetrahydroindazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a quinoline group, an isoquinoline group, an indole group, a benzimidazole group, a dibenzofuran group and a dibenzothiophene group; A 3 and A 4At least one of the groups may be selected from the group consisting of a pyrazole group, an indazole group, a tetrahydroindazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a quinoline group, an isoquinoline group, an indole group, and a benzimidazole group, but is not limited thereto.
[0015] As yet another example, in Chemical Formula 1, A 1 ~A 4 are each independently selected from the group consisting of a benzene group, a naphthalene group, a pyridine group, a pyrimidine group, a pyrazine group, a quinoline group, an isoquinoline group, a dibenzofuran group, and a dibenzothiophene group; A 3 and A 4 At least one of the groups may be selected from the group consisting of a pyridine group, a pyrimidine group, a pyrazine group, a quinoline group, and an isoquinoline group, but is not limited thereto. As yet another example, in Formula 1, A 1 ~A 4 are each independently selected from the group consisting of a benzene group, a naphthalene group, a pyridine group, a pyrimidine group, a quinoline group, an isoquinoline group, and a dibenzofuran group; A 3 and A 4 At least one of the groups may be selected from the group consisting of a pyridine group, a pyrimidine group, a quinoline group, and an isoquinoline group, but is not limited thereto.
[0016] In Chemical Formula 1, X 1 ~X 4 are each independently selected from carbon atoms (C) and nitrogen atoms (N); 3 and X 4 At least one of is N. For example, in Chemical Formula 1, X 1 and X 2 is C, X 3 and X 4 are each independently selected from C and N, 3 and X 4At least one of the following is also N, but is not limited thereto. As another example, in formula 1, X 1 and X 2 is C, X 3 and X 4 is also N, but is not limited thereto.
[0017] In Chemical Formula 1, B 1 ~B 4 are also independently selected from a single bond, O and S. For example, in Chemical Formula 1, B 1 ~B 4 can also be, but is not limited to, a single bond.
[0018] In Chemical Formula 1, Y 1 ~Y 3 are each independently selected from a single bond and a divalent linking group, 1 ~Y 3 At least one of the groups is a divalent linking group. For example, Y 1 and Y 2 is a single bond, and Y 3 is a divalent linkage, or Y 2 and Y 3 is a single bond, and Y 1 is a divalent linkage, or Y 3 and Y 1 is a single bond, and Y 2 is also a divalent linking group, but is not limited thereto. As another example, in Formula 1, Y 1 and Y 2 is a divalent linking group, Y 3 is a divalent single bond or Y 2 and Y 3 is a divalent linking group, Y 1 is a divalent single bond or Y 3 and Y 1is a divalent linking group, Y 2 is also, but is not limited to, a divalent single bond.
[0019] As yet another example, Y 1 ~Y 3 is also a divalent linking group, but is not limited thereto. For example, in Formula 1, Y 1 ~Y 3 are each independently selected from a single bond and a divalent linking group, 1 ~Y 3 At least one of the groups is a divalent linking group, The divalent linking group is *-O-*', *-S-*, *-{B(R 81 )}-*', *-{N(R 81 )}-*', *-{C(R 81 )(R 82 )} n81 -*', *-{Si(R 81 )(R 82 )} n81 -*', substituted or unsubstituted C 2 -C 20 Alkenylene group, substituted or unsubstituted C 2 -C 20 Alkynylene group, substituted or unsubstituted C 6 -C 20 Arylene groups, substituted or unsubstituted C 1 -C 20 is selected from the group consisting of a heteroarylene group, a substituted or unsubstituted divalent non-aromatic fused polycyclic group, and a substituted or unsubstituted divalent non-aromatic fused polycyclic heterocyclic group; R 81 and R 82 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphate group or a salt thereof, C 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group; 1 -C 20 Alkyl group and C 1 -C 20 Alkoxy groups, A phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, cinnolinyl group, carbazolyl group, phenanthrolinyl group, benzimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzoxazolyl group, triazolyl group, tetrazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, and imidazopyridinyl group, as well as Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20Alkoxy group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolyl group, indolyl group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and -Si(Q 1 )(Q 2 )(Q 3 a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoxyl group, R is selected from the group consisting of a quinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, and an imidazopyridinyl group; 81 and R 82can optionally be joined together to form a saturated or unsaturated ring, Q 1 ~Q 3 are independently hydrogen, deuterium, and C 1 -C 20 selected from the group consisting of alkyl and phenyl groups; n1 is selected from the group consisting of 1, 2, 3, 4 and 5; * and *' may each independently be a bond site with an adjacent atom, but are not limited thereto.
[0020] As another example, in Formula 1, Y 1 ~Y 3 are each independently selected from a single bond and a divalent linking group, 1 ~Y 3 At least one of the groups is a divalent linking group, The divalent linking group is *-O-*', *-S-*, *-{B(R 81 )}-*', *-{N(R 81 )}-*', *-{C(R 81 )(R 82 )} n81 -*', *-{Si(R 81 )(R 82 )} n81 -*', a substituted or unsubstituted ethenylene group, a substituted or unsubstituted propenylene group, a substituted or unsubstituted butenylene group, a substituted or unsubstituted pentenylene group, a substituted or unsubstituted phenylene group, a substituted or unsubstituted naphthylene group, a substituted or unsubstituted fluorenylene group, a substituted or unsubstituted pyridinylene group, a substituted or unsubstituted pyrazinylene group, a substituted or unsubstituted pyrimidinylene group, a substituted or unsubstituted quinolinylene group, a substituted or unsubstituted isoquinolinylene group, a substituted or unsubstituted naphthyridinylene group, a substituted or unsubstituted quinoxalinylene group, a substituted or unsubstituted quinazolinylene group, a substituted or unsubstituted dibenzofuranylene group, and a substituted or unsubstituted dibenzothiophenylene group; R 81 and R 82are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphate group or a salt thereof, C 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group; 1 -C 20 Alkyl group and C 1 -C 20 Alkoxy groups, A phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, cinnolinyl group, carbazolyl group, phenanthrolinyl group, benzimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzoxazolyl group, triazolyl group, tetrazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, and imidazopyridinyl group, as well as Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , -Si(CH3 ) 3 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20Alkoxy group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolyl group, indolyl group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group at least one of a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, and an imidazopyridinyl group; a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, or an isoquinolinyl group, R is selected from the group consisting of benzoquinolinyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, phenanthrolinyl, benzimidazolyl, benzofuranyl, benzothiophenyl, isobenzothiazolyl, benzoxazolyl, isobenzoxazolyl, triazolyl, tetrazolyl, oxadiazolyl, triazinyl, dibenzofuranyl, dibenzothiophenyl, benzocarbazolyl, dibenzocarbazolyl, and imidazopyridinyl; 81 and R 82 can optionally be linked together to form a saturated or unsaturated ring; n1 is selected from the group consisting of 1, 2, 3, 4 and 5; * and *' may each independently be a bond site with an adjacent atom, but are not limited thereto.
[0021] As yet another example, in Formula 1, Y 1 ~Y 3 are each independently selected from a single bond and a divalent linking group, 1 ~Y 3 At least one of the groups is a divalent linking group, The divalent linking group may be represented by *-O-*', *-S-*', or any one of the chemical formulas (8-1) to (8-18) shown below, but is not limited thereto. [ka] [ka] [ka] [ka]
[0022] In chemical formulas (8-1) to (8-18), R 81 ~R 88 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphate group or a salt thereof, C 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group;1 -C 20 Alkyl group and C 1 -C 20 Alkoxy groups, A phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, cinnolinyl group, carbazolyl group, phenanthrolinyl group, benzimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzoxazolyl group, triazolyl group, tetrazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, and imidazopyridinyl group, as well as Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , -Si(CH 3 ) 3 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20Alkoxy group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolyl group, indolyl group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group at least one of a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, and an imidazopyridinyl group; phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolyl group, indolyl group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group , a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, and an imidazopyridinyl group; n81 is selected from 1, 2, 3, 4, and 5; * and *' are, independently of each other, bond sites to adjacent atoms.
[0023] As another example, in the chemical formulas (8-1) to (8-18), R 81 ~R 88 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, cyano, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, and tert-butoxy; C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a cyano group, a phenyl group, and a naphthyl group; 1 -C 20 Alkyl group and C 1 -C 20 Alkoxy groups, Phenyl, naphthyl, pyridinyl, and dibenzofuranyl groups, and Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , -Si(CH 3 ) 3 , cyano, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, tert-butoxy, phenyl, naphthyl, pyridinyl, and dibenzofuranyl substituted with at least one of phenyl, naphthyl, and pyridinyl; n81 can also be selected from 1 and 2, but is not limited thereto.
[0024] As yet another example, in Formula 1, Y 1 ~Y 3 are each independently selected from a single bond and a divalent linking group, 1 ~Y 3 At least one of the groups is a divalent linking group, The divalent linking group may be represented by *-O-*', *-S-*', or any one of the chemical formulas (9-1) to (9-70) shown below, but is not limited thereto. [ka] [ka] [ka] [ka] [ka] [ka] [ka]
[0025] In chemical formulas (9-1) to (9-70), Ph is a phenyl group; 2-pyr is a 2-pyridinyl group, 3-pyr is a 3-pyridinyl group, and 4-pyr is a 4-pyridinyl group; * and *' are, independently of each other, bond sites to adjacent atoms.
[0026] In Chemical Formula 1, Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-1) to (2-4). [ka]
[0027] In the chemical formulas (2-1) to (2-4), Y 21 and Y 22 are each independently a substituted or unsubstituted C1 -C 10 Alkylene groups and substituted or unsubstituted C 2 -C 10 alkenylene groups, a21 and a22 are independently selected from the group consisting of 0, 1, 2, 3, 4, and 5; R 21 ~R 27 are each independently hydrogen, deuterium, substituted or unsubstituted C 1 -C 60 Alkyl groups, substituted or unsubstituted C 2 -C 60 Alkenyl groups, substituted or unsubstituted C 2 -C 60 Alkynyl groups, substituted or unsubstituted C 1 -C 60 Alkoxy groups, substituted or unsubstituted C 3 -C 10 Cycloalkyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkyl groups, substituted or unsubstituted C 3 -C 10 Cycloalkenyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl groups, substituted or unsubstituted C 6 -C 60 Aryl groups, substituted or unsubstituted C 6 -C 60 Aryloxy groups, substituted or unsubstituted C 6 -C 60 Arylthio groups, substituted or unsubstituted C 7 -C 60 Arylalkyl groups, substituted or unsubstituted C 1 -C 60 Heteroaryl groups, substituted or unsubstituted C 1 -C 60 Heteroaryloxy groups, substituted or unsubstituted C 1 -C 60 Heteroarylthio groups, substituted or unsubstituted C 2 -C 60is selected from the group consisting of heteroarylalkyl groups, substituted or unsubstituted monovalent non-aromatic fused polycyclic groups, and substituted or unsubstituted monovalent non-aromatic fused polycyclic heterocyclic groups; * indicates a bonding site with an adjacent atom.
[0028] For example, in the chemical formulas (2-1) to (2-4), Y 21 and Y 22 are, independently of one another, a methylene group, an ethylene group, and a propylene group, and Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , and C 1 -C 20 selected from the group consisting of methylene, ethylene, and propylene, substituted with at least one alkyl group; a21 and a22 are each independently selected from 0, 1, 2, and 3, but are not limited thereto.
[0029] As another example, in the chemical formulas (2-1) to (2-4), Y 21 and Y 22 are each independently selected from the group consisting of a methylene group, an ethylene group, and a propylene group; a21 and a22 are each independently selected from 0, 1 and 2, but are not limited thereto. For example, in the chemical formulas (2-1) to (2-4), R 21 =R 22 =R 23 or R 21 =R 22 And R 22 ≠R 23 or R 21 ≠R 22 And R 22 ≠R 23 And R 23 ≠R 21However, it is not limited to these.
[0030] As another example, in the chemical formulas (2-1) to (2-4), R 21 ~R 27 are independent of each other, Hydrogen, Deuterium, C 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group. 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, Cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclooctyl group, adamantanyl group, norbornanyl group, norbornenyl group, cyclopentenyl group, cyclohexenyl group, cycloheptenyl group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolinyl group, a phenyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group; Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20Alkoxy group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclooctyl group, adamantanyl group, norbornanyl group, norbornenyl group, cyclopentenyl group, cyclohexenyl group, cycloheptenyl group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, Azinyl group, a pyrimidinyl group, a pyridazinyl group, a isoindolyl group, a indolyl group, a indazolyl group, a purinyl group, a quinolinyl group, a isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzoca a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazo, a cyclopentyl group, a cyclohex ...octyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazo, a cyclopentyl group, a cyclohexyl group, a cyclohexyl group, a cyclohexenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a an aryl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group,Also selected from the group consisting of, but not limited to, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group.
[0031] As another example, in the chemical formulas (2-1) to (2-4), R 21 ~R 27 are independent of each other, Hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, iso-pentyl, sec-pentyl, and tert-pentyl; methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, and tert-pentyl groups substituted with at least one of deuterium and phenyl; Phenyl and naphthyl groups, and Deuterium, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , C 1 -C 20 Also selected from, but not limited to, phenyl and naphthyl groups substituted with at least one of an alkyl group and a phenyl group.
[0032] As another example, in the chemical formulas (2-1) to (2-4), R 21 ~R 27 are independent of each other, It may also be selected from, but is not limited to, hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, phenyl, and naphthyl.
[0033] In one embodiment, in the chemical formulas (2-1) and (2-2), R 21 and R 22 are each independently a substituted or unsubstituted C 6 -C 60 Aryl groups, substituted or unsubstituted C 1 -C 60 is selected from the group consisting of a heteroaryl group, a substituted or unsubstituted monovalent non-aromatic fused polycyclic group, and a substituted or unsubstituted monovalent non-aromatic fused polycyclic heterocyclic group; R 23 is a substituted or unsubstituted C 1 -C 60 The alkyl group may be selected from, but is not limited to, alkyl groups.
[0034] In another embodiment, in formula (2-1) and (2-2), R 21 and R 22 are each independently a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group; Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20Alkoxy group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclooctyl group, adamantanyl group, norbornanyl group, norbornenyl group, cyclopentenyl group, cyclohexenyl group, cycloheptenyl group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group , pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolyl group, indolyl group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, cinnolinyl group, carbazolyl group, phenanthrolinyl group, benzimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzoxazolyl group, triazolyl group, tetrazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an in ... a doryl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group,and an imidazopyrimidinyl group, R 23 is C 1 -C 20 Alkyl groups, and C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group; 1 -C 20 The alkyl group may be selected from, but is not limited to, alkyl groups.
[0035] In still other embodiments, in the chemical formulas (2-1) and (2-2), R 21 and R 22 are independent of each other, Phenyl and naphthyl groups, and Deuterium, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , C 1 -C 20 selected from the group consisting of phenyl and naphthyl, substituted with at least one of an alkyl group and a phenyl group; R 23 means methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl and tert-pentyl groups, and Also selected from, but not limited to, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-pentyl, iso-pentyl, sec-pentyl, and tert-pentyl groups substituted with at least one of deuterium and phenyl.
[0036] In still other embodiments, in formula (2-1) and (2-2), R 21 and R 22 are each independently selected from the group consisting of a phenyl group and a naphthyl group, R 23 is also selected from, but is not limited to, a methyl group, an ethyl group, a n-propyl group, an iso-propyl group, a n-butyl group, an iso-butyl group, a sec-butyl group, and a tert-butyl group. For example, in formula 1, Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-11) to (2-20), but are not limited thereto. [ka] In chemical formulas (2-11) to (2-20), R 21 ~R 23 are independently selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, phenyl and naphthyl; * indicates a bonding site with an adjacent atom.
[0037] As another example, in the chemical formulas (2-11) to (2-20), R 21 =R 22 =R 23 or R 21 =R 22 And R 22 ≠R 23 or R21 ≠R 22 And R 22 ≠R 23 And R 23 ≠R 21 However, it is not limited to these.
[0038] As another example, in formula 1, Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-21) to (2-34), but are not limited thereto. [ka] [ka] In the chemical formulas (2-21) to (2-34), Et is an ethyl group; Ph is a phenyl group; * indicates a bonding site with an adjacent atom.
[0039] In one embodiment, in Formula 1, Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-2) to (2-4), but are not limited thereto. [ka] In chemical formulas (2-2) to (2-4), Y 21 , Y 22 , a21, a22, and R 21 ~R 2 7 for the explanation of chemical formulas (2-1) to (2-4).
[0040] In other embodiments, in Formula 1, Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-12) to (2-20), but are not limited thereto. [ka] In chemical formulas (2-12) to (2-20), R 21 ~R 23 are independently selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, phenyl and naphthyl; * indicates a bonding site with an adjacent atom.
[0041] As another example, in the chemical formulas (2-11) to (2-20), R 21 =R 22 =R 23 or R 21 =R 22 And R 22 ≠R 23 or R 21 ≠R 22 And R 22 ≠R 23 And R 23 ≠R 21 However, it is not limited to these.
[0042] In still other embodiments, in Formula 1, Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-26) to (2-34), but are not limited thereto. [ka] [ka] In chemical formulas (2-26) to (2-34), Et is an ethyl group; Ph is a phenyl group; * indicates a bonding site with an adjacent atom.
[0043] In Chemical Formula 1, d1 is Z1 , and is selected from 0, 1, 2, 3, and 4. If d1 is 2 or more, 1 may be the same or different from each other. In Chemical Formula 1, d2 is Z 2 , and is selected from 0, 1, 2, 3, and 4. If d2 is 2 or more, 2 may be the same or different from each other. In Chemical Formula 1, X 3 If N, then d1 is selected from 1, 2, 3, and 4, or X 4 If is N, then d2 is also selected from 1, 2, 3 and 4. For example, in Formula 1, d1 and d2 are independently selected from 0, 1, and 2; At least one of d1 and d2 may be selected from 1 and 2, but is not limited thereto. As another example, in Chemical Formula 1, d1 and d2 can be 1, but are not limited thereto.
[0044] In Chemical Formula 1, R 1 ~R 4 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 Alkyl groups, substituted or unsubstituted C 2 -C 60 Alkenyl groups, substituted or unsubstituted C 2 -C 60 Alkynyl groups, substituted or unsubstituted C 1 -C 60 Alkoxy groups, substituted or unsubstituted C 3 -C 10 Cycloalkyl groups, substituted or unsubstituted C 1 -C 10Heterocycloalkyl groups, substituted or unsubstituted C 3 -C 10 Cycloalkenyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl groups, substituted or unsubstituted C 6 -C 60 Aryl groups, substituted or unsubstituted C 6 -C 60 Aryloxy groups, substituted or unsubstituted C 6 -C 60 Arylthio groups, substituted or unsubstituted C 7 -C 60 Arylalkyl groups, substituted or unsubstituted C 1 -C 60 Heteroaryl groups, substituted or unsubstituted C 1 -C 60 Heteroaryloxy groups, substituted or unsubstituted C 1 -C 60 Heteroarylthio groups, substituted or unsubstituted C 2 -C 60 Heteroarylalkyl groups, substituted or unsubstituted monovalent non-aromatic condensed polycyclic groups, substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic groups, -C(=O)(Q 7 ), and -N(Q 7 )(Q 8 ), and R 1 and R 4 , or R 2 and R 3 can optionally be linked together to form a saturated or unsaturated ring; Q 7 and Q 8 are independent of each other, C 1 -C 60 Alkyl group and C 6 -C 60 It is also selected from among aryl groups.
[0045] For example, in Formula 1, R 1 ~R 4 are independently hydrogen, deuterium, and C 1 -C 20 Alkyl groups and C 1-C 20 Alkoxy groups, C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group; 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, Cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclooctyl group, adamantanyl group, norbornanyl group, norbornenyl group, cyclopentenyl group, cyclohexenyl group, cycloheptenyl group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolinyl group, a phenyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group; Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20Alkoxy group, cyclopentyl group, cyclohexyl group, cycloheptyl group, cyclooctyl group, adamantanyl group, norbornanyl group, norbornenyl group, cyclopentenyl group, cyclohexenyl group, cycloheptenyl group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, Azinyl group, a pyrimidinyl group, a pyridazinyl group, a isoindolyl group, a indolyl group, a indazolyl group, a purinyl group, a quinolinyl group, a isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzoca a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazo, a cyclopentyl group, a cyclohex ...octyl group, an adamantanyl group, a norbornanyl group, a norbornenyl group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazo, a cyclopentyl group, a cyclohexyl group, a cyclohexyl group, a cyclohexenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a phenyl group, a an aryl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group,Also selected from the group consisting of, but not limited to, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinyl group, and an imidazopyrimidinyl group.
[0046] As another example, in Formula 1, R 1 ~R 4 are each independently hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl and tert-pentyl, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, and tert-pentyl groups substituted with at least one of deuterium and phenyl; Phenyl, naphthyl and carbazolyl groups, and Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , C 1 -C 20 Also selected from, but not limited to, phenyl, naphthyl, and carbazolyl groups substituted with at least one of alkyl, phenyl, and naphthyl groups.
[0047] As yet another example, in Formula 1, R 1 ~R 4 are each independently hydrogen, deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl and tert-pentyl, Phenyl and carbazolyl groups, and C 1 -C 20 Also selected from, but not limited to, phenyl, naphthyl, and carbazolyl groups substituted with at least one of an alkyl group and a phenyl group.
[0048] In Chemical Formula 1, b1 is R 1 where b1 is selected from 1, 2, 3, and 4. When b1 is 2 or more, a plurality of R 1 may be the same or different from each other. In Chemical Formula 1, b2 is R 2 and b2 is also selected from 1, 2, 3, and 4. When b2 is 2 or more, a plurality of R 2 may be the same or different from each other. In Chemical Formula 1, b3 is R 3 and b3 is also selected from 1, 2, 3, and 4. When b3 is 2 or more, a plurality of R 3 may be the same or different from each other. In Chemical Formula 1, b4 is R 4 and b4 is selected from 1, 2, 3, and 4. When b4 is 2 or more, a plurality of R 4 may be the same or different from each other.
[0049] In Chemical Formula 1, L 1 is selected from monodentate and bidentate ligands. Examples of monodentate ligands are iodide, bromide, chloride, sulfide, thiocyanate, nitrate, azide, hydroxide, cyanide, isocyanide, water, acetonitrile, pyridine, ammonia, carbon monoxide, and PPh. 3 , PPh 2 CH 3 , PPh(CH 3 ) 2 , P(CH 3) 3 These include, but are not limited to, the following: Examples of bidentate ligands include, but are not limited to, oxalate, acetylacetonate, picolinic acid, 2-(2-hydroxyphenyl)-pyridine, 2-phenylpyridine, 1,2-bis(diphenylphosphino)ethane (dppe), 1,1-bis(diphenylphosphino)methane (dppm), glycinate, ethylenediamine, 2,2'-bipyridine, and 1,10-phenanthroline.
[0050] For example, in formula 1, L 1 is represented by any one of the following chemical formulas (3-1) to (3-6), but is not limited thereto. [ka]
[0051] In chemical formulas (3-1) to (3-6), A 31 is C 5 -C 20 Carbocyclic groups and C 1 -C 20 heterocyclic groups, X 31 and X 32 are independently selected from C and N, Y 31 is a single bond, a carbon-carbon double bond, a substituted or unsubstituted C 1 -C 5 Alkylene groups, substituted or unsubstituted C2-C5 alkenylene groups, and substituted or unsubstituted C 6 -C 10 arylene groups, Z 31 and Z 32 are independent of each other, N, O, and N(R 34 ), P(R 34 )(R 35 ) and As(R 34 )(R 35 ), Z33 is selected from P and As; R 31 ~R 35 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 Alkyl groups, substituted or unsubstituted C 2 -C 60 Alkenyl groups, substituted or unsubstituted C 2 -C 60 Alkynyl groups, substituted or unsubstituted C 1 -C 60 Alkoxy groups, substituted or unsubstituted C 3 -C 10 Cycloalkyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkyl groups, substituted or unsubstituted C 3 -C 10 Cycloalkenyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl groups, substituted or unsubstituted C 6 -C 60 Aryl groups, substituted or unsubstituted C 6 -C 60 Aryloxy groups, substituted or unsubstituted C 6 -C 60 Arylthio groups, substituted or unsubstituted C 7 -C 60 Arylalkyl groups, substituted or unsubstituted C 1 -C 60 Heteroaryl groups, substituted or unsubstituted C 1 -C 60 Heteroaryloxy groups, substituted or unsubstituted C 1 -C 60 Heteroarylthio groups, substituted or unsubstituted C 2 -C 60is selected from the group consisting of heteroarylalkyl groups, substituted or unsubstituted monovalent non-aromatic fused polycyclic groups, and substituted or unsubstituted monovalent non-aromatic fused polycyclic heterocyclic groups; b31 is selected from 1, 2, and 3; * and *' are, independently of each other, bond sites to adjacent atoms.
[0052] For example, in the chemical formulas (3-1) to (3-6), A 31 is also selected from, but is not limited to, benzene, naphthalene, pyridine, pyrimidine, triazine, quinoline, and isoquinoline. For example, in the chemical formulas (3-1) to (3-6), Y 31 is also selected from, but is not limited to, a substituted or unsubstituted methylene group, and a substituted or unsubstituted phenylene group. For example, in the chemical formulas (3-1) to (3-6), Z 33 is also P, but is not limited to it.
[0053] For example, in the chemical formulas (3-1) to (3-6), R 31 ~R 35 are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphate group or a salt thereof, C 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, C substituted with at least one of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinyl group; 1 -C 20 Alkyl groups and C 1 -C 20 Alkoxy groups, A phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a fluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, an indazolyl group, a purinyl group, a quinolinyl group, an isoquinolinyl group, benzoquinolinyl group, quinoxalinyl group, quinazolinyl group, cinnolinyl group, carbazolyl group, phenanthrolinyl group, benzimidazolyl group, benzofuranyl group, benzothiophenyl group, isobenzothiazolyl group, benzoxazolyl group, isobenzoxazolyl group, triazolyl group, tetrazolyl group, oxadiazolyl group, triazinyl group, dibenzofuranyl group, dibenzothiophenyl group, benzocarbazolyl group, dibenzocarbazolyl group, and imidazopyridinyl group, as well as Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20Alkoxy group, phenyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolyl group, indolyl group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoxyl a phenyl group substituted with at least one of a phenyl group, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, and an imidazopyridinyl group; nyl group, naphthyl group, fluorenyl group, phenanthrenyl group, anthracenyl group, fluoranthenyl group, triphenylenyl group, pyrenyl group, chrysenyl group, pyrrolyl group, thiophenyl group, furanyl group, imidazolyl group, pyrazolyl group, thiazolyl group, isothiazolyl group, oxazolyl group, isoxazolyl group, pyridinyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, isoindolyl group, indolyl group, indazolyl group, purinyl group, quinolinyl group, isoquinolinyl group, benzoquinolinyl group, quinox Also selected from among a salinyl group, a quinazolinyl group, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group, a benzimidazolyl group, a benzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolyl group, and an imidazopyridinyl group, but are not limited thereto.
[0054] As another example, in Formula 1, L 1is represented by any one of the following chemical formulas (4-1) to (4-5), but is not limited thereto. [ka] In chemical formulas (4-1) to (4-5), Ph is a phenyl group; * and *' are bonding sites with adjacent atoms.
[0055] In Chemical Formula 1, a1 is L 1 where a1 is selected from 0, 1, and 2. When a1 is 2, a plurality of L 1 may be the same or different from each other. For example, in Chemical Formula 1, a1 can be 0, but is not limited thereto. As another example, in Chemical Formula 1, M is Pt and a1 is 0, but is not limited thereto. As yet another example, in Chemical Formula 1, M is Os and a1 is 2, but this is not limited thereto.
[0056] The organometallic compound represented by Chemical Formula 1 may be represented by any one of Chemical Formulas (1-1) to (1-3) shown below, but is not limited thereto. [ka] In chemical formulas (1-1) to (1-3), M, A1~A4, X 1 ~X 4 , Z 1 , Z 2 , d1, d2, R 1 ~R 4 , b1~b4, L 1 and a1 are as defined in Chemical Formula 1; Y 1 ~Y 3 are each independently a divalent linking group.
[0057] For example, in the chemical formulas (1-1) to (1-3), M is selected from the group consisting of Ir, Pt, and Os; A 1 ~A 4 are each independently selected from the group consisting of a benzene group, a naphthalene group, a pyridine group, a pyrimidine group, a quinoline group, and an isoquinoline group; A 3 and A 4 at least one of is selected from the group consisting of a pyridine group, a pyrimidine group, a quinoline group, and an isoquinoline group; X 1 and X 2 is C, X 3 and X 4 are each independently selected from C and N, 3 and X 4 At least one of the is also N, but is not limited to this.
[0058] The organometallic compound represented by Chemical Formula 1 may be represented by any one of Chemical Formulas (1-11) to (1-13) shown below, but is not limited thereto. [ka] In chemical formulas (1-11) to (1-13), M.A. 1 ~A 4 , X 1 ~X 3 , Z 1 , Z 2 , R 1 ~R 4 , b1~b4, L 1 and a1 are as defined in Chemical Formula 1; Y 1 ~Y 3 are, independently of each other, a divalent linking group, d1 is selected from 0, 1, 2, 3, and 4; d2 is selected from 1, 2, 3, and 4.
[0059] For example, in the chemical formulas (1-11) to (1-13), Z 1 and Z 2 are each independently represented by any one of chemical formulas (2-21) to (2-34), but are not limited thereto. As another example, in the chemical formulas (1-11) to (1-13), M is Pt and a1 is 0, but the present invention is not limited thereto.
[0060] The organometallic compound represented by Chemical Formula 1 may be represented by any one of Chemical Formulas (1-14) to (1-16) shown below, but is not limited thereto. [ka] In chemical formulas (1-14) to (1-16), M.A. 1 ~A 4 , X 1 , X 2 , X 4 , Z 1 and Z 2 , R 1 ~R 4 , b1~b4, L 1 and a1 are as defined in Chemical Formula 1; Y 1 ~Y 3 are, independently of each other, a divalent linking group, d1 is selected from 1, 2, 3, and 4; d2 is selected from 0, 1, 2, 3, and 4. For example, in the chemical formulas (1-14) to (1-16), Z 1 and Z 2 are each independently represented by any one of chemical formulas (2-21) to (2-34), but are not limited thereto. As another example, in the chemical formulas (1-14) to (1-16), M is Pt and a1 is 0, but the present invention is not limited thereto.
[0061] The organometallic compound represented by Chemical Formula 1 may be represented by any one of Chemical Formulas (1-17) to (1-19) shown below, but is not limited thereto. [ka] In chemical formulas (1-17) to (1-19), M.A. 1 ~A 4 , X 1 , X 2 , Z 1 and Z 2 , R 1 ~R 4 , b 1 ~b 4 , L 1 and a1 are as defined in Chemical Formula 1; Y 1 ~Y 3 are, independently of each other, a divalent linking group, d1 is selected from 1, 2, 3, and 4; d2 is selected from 1, 2, 3, and 4. For example, in the chemical formulas (1-17) to (1-19), Z 1 and Z 2 are each independently represented by any one of chemical formulas (2-21) to (2-34), but are not limited thereto. As another example, in the chemical formulas (1-17) to (1-19), M is Pt and a1 is 0, but the invention is not limited thereto.
[0062] The organometallic compound represented by Chemical Formula 1 is also selected from the following Compounds 1 to 18 and Chemical Formulas 20 to 37, but is not limited thereto. TIFF0007594622000029.tif99160TIFF0007594622000030.tif96163TIFF0007594622000031.tif91167TIFF0007594622000032.tif100167TIFF0007594622000033.tif62128In compounds 1 to 18 and chemical formulas 20 to 37, TMS is the trimethylsilyl group.
[0063] In the organometallic compound represented by chemical formula 1, as represented by chemical formula 1B shown below, the N-containing ring is necessarily substituted with a group represented by any one of chemical formulas (2-1) to (2-4). [ka]
[0064] In a group represented by any one of chemical formulas (2-1) to (2-4), electrons fill the vacant d-orbitals of Si or Ge. Therefore, when a group represented by any one of chemical formulas (2-1) to (2-4) is substituted with a ring containing N, when electrons and / or energy are transferred to the organometallic compound represented by chemical formula 1, the chemical, physical, and electrical stability of the organometallic compound represented by chemical formula 1 is increased. Therefore, the life of the organic light emitting device including the organometallic compound represented by Chemical Formula 1 is improved.
[0065] Furthermore, when a group represented by any one of chemical formulas (2-1) to (2-4) is introduced into the organometallic compound represented by chemical formula 1, steric hindrance increases, and the organometallic compound represented by chemical formula 1 has a non-planar structure. Since the organometallic compound represented by Chemical Formula 1 has a non-planar structure, aggregation is less likely to occur, and the efficiency of an organic light emitting device including the organometallic compound represented by Chemical Formula 1 is improved.
[0066] Those skilled in the art will be able to recognize how to synthesize the organometallic compound represented by Chemical Formula 1 by referring to the synthesis examples described below. Therefore, the organometallic compound represented by Chemical Formula 1 is suitable for use as a dopant in an organic layer of an organic light-emitting element, for example, in an organic layer that is an emitting layer. Another object of the present invention is to provide an organic light-emitting element having a first electrode, a second electrode, and an organic layer interposed between the first electrode and the second electrode, including a emitting layer and including at least one organometallic compound represented by Chemical Formula 1.
[0067] The organometallic compound represented by Chemical Formula 1 is used between a pair of electrodes of an organic light emitting device. For example, the organometallic compound represented by Chemical Formula 1 is contained in the light-emitting layer. In this case, the organometallic compound may act as a dopant, and the light-emitting layer may further include a host (ie, the content of the organometallic compound represented by Chemical Formula 1 is less than the content of the host). In this specification, "(the organic layer) contains one or more organometallic compounds" is to be interpreted as "(the organic layer) may contain one organometallic compound belonging to the category of Chemical Formula 1, or two or more different organometallic compounds belonging to the category of Chemical Formula 1." For example, the organic layer may contain only Compound 1 as the organometallic compound. In this case, compound 1 can be present in the light-emitting layer of the organic light-emitting device. Alternatively, the organic layer may contain Compound 1 and Compound 2 as organometallic compounds. In this case, compound 1 and compound 2 can be present in the same layer (for example, compound 1 and compound 2 can both be present in the light-emitting layer).
[0068] The first electrode is an anode that is a hole-injection electrode and the second electrode is a cathode that is an electron-injection electrode, or the first electrode is a cathode that is an electron-injection electrode and the second electrode is an anode that is a hole-injection electrode. For example, the first electrode is an anode, the second electrode is a cathode, and the organic layer is i) a hole transport region interposed between the first electrode and the light emitting layer, the hole transport region including at least one layer selected from the group consisting of a hole injection layer, a hole transport layer, and an electron blocking layer; ii) an electron transport region interposed between the light-emitting layer and the second electrode, the electron transport region including at least one layer selected from the group consisting of a hole blocking layer, an electron transport layer, and an electron injection layer.
[0069] FIG. 1 is a cross-sectional view illustrating a schematic structure of an organic light-emitting device 10 according to one embodiment of the present invention. Hereinafter, a structure and a method for manufacturing an organic light emitting device according to an embodiment of the present invention will be described with reference to FIG. The organic light emitting element 10 has a structure in which a first electrode 11, an organic layer 15, and a second electrode 19 are laminated in this order.
[0070] An additional substrate is disposed below the first electrode 11 or above the second electrode 19 . As the substrate, a substrate used in a general organic light-emitting device can be used, but a glass substrate or a transparent plastic substrate having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and waterproofness can also be used.
[0071] The first electrode 11 is formed, for example, by providing a material for the first electrode on the substrate by using a deposition method or a sputtering method. The first electrode 11 is also an anode. The material for the first electrode is selected from materials having a high work function so that holes can be easily injected. The first electrode 11 may be a reflective electrode, a semi-transparent electrode, or a transmissive electrode. The first electrode material is indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO 2 ), zinc oxide (ZnO), etc. can be used. Alternatively, metals such as magnesium (Mg), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag) can be used. The first electrode 11 can have a single layer structure or a multi-layer structure including two or more layers. For example, the first electrode 11 can have a three-layer structure of ITO / Ag / ITO, but is not limited thereto.
[0072] On top of the first electrode 11, an organic layer 15 is disposed. Organic layers 15 may include a hole transport region, an emission layer, and an electron transport region. The hole transport region is disposed between the first electrode 11 and the light emitting layer. The hole transport region may include at least one of a hole injection layer, a hole transport layer, an electron blocking layer, and a buffer layer. The hole transport region may include only a hole injection layer or only a hole transport layer. Alternatively, the hole transport region may have a structure of a hole injection layer / hole transport layer, or a hole injection layer / hole transport layer / electron blocking layer, which are laminated in this order from the first electrode 11 onwards.
[0073] When the hole transport region includes a hole injection layer, the hole injection layer (HIL) is formed on the first electrode 11 using various methods such as vacuum deposition, spin coating, casting, and Langmuir-Blodgett (LB) method. When the hole injection layer is formed by vacuum deposition, the deposition conditions vary depending on the compound used as the hole injection layer material, the structure and thermal properties of the intended hole injection layer, and the like. For example, the deposition temperature is about 100 to about 500° C., the vacuum degree is about 10 -8 ~about 10 -3 Torr and a deposition rate of about 0.01 to about 100 Å / sec, but are not limited thereto. When the hole injection layer is formed by a spin coating method, the coating conditions vary depending on the compound used as the hole injection layer material and the structure and thermal properties of the intended hole injection layer, but are not limited to a coating speed of about 2,000 rpm to about 5,000 rpm and a heat treatment temperature for removing the solvent after coating selected from the temperature range of about 80°C to 200°C.
[0074] The conditions for forming the hole transport layer and the electron blocking layer are the same as those for forming the hole injection layer. The hole transport region may include at least one of, for example, m-MTDATA, TDATA, 2-TNATA, NPB, β-NPB, TPD, spiro-TPD, spiro-NPB, methylated-NPB, TAPC, HMTPD, 4,4',4"-tris(N-carbazolyl)triphenylamine (TCTA), polyaniline / dodecylbenzenesulfonic acid (PANI / DBSA), poly(3,4-ethylenedioxythiophene) / poly(4-styrenesulfonate) (PEDOT / PSS), polyaniline / camphorsulfonic acid (PANI / CSA), polyaniline / poly(4-styrenesulfonate) (PANI / PSS), a compound represented by chemical formula 201 shown below, and a compound represented by chemical formula 202 shown below. TIFF0007594622000035.tif66161TIFF0007594622000036.tif102153 [ka] [ka]
[0075] In the formula 201, Ar 101 and Ar 102 are independent of each other, a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an acenaphthylene group, a fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, and a pentacenylene group, and Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphate group or salt thereof, C1 -C 60 Alkyl group, C 2 -C 60 Alkenyl group, C 2 -C 60 Alkynyl group, C 1 -C 60 Alkoxy group, C 3 -C 10 Cycloalkyl groups, C 3 -C 10 Cycloalkenyl group, C 1 -C 10 Heterocycloalkyl groups, C 1 -C 10 Heterocycloalkenyl group, C 6 -C 60 Aryl group, C 6 -C 60 Aryloxy group, C 6 -C 60 Arylthio group, C 7 -C 60 Arylalkyl groups, C 1 -C 60 Heteroaryl groups, C 1 -C 60 Heteroaryloxy group, C 1 -C 60 Heteroarylthio groups, C 2 -C 60 The heteroaryl group is selected from a phenylene group, a pentalenylene group, an indenylene group, a naphthylene group, an azulenylene group, a heptalenylene group, an acenaphthylene group, a fluorenylene group, a phenalenylene group, a phenanthrenylene group, an anthracenylene group, a fluoranthenylene group, a triphenylenylene group, a pyrenylene group, a chrysenylenylene group, a naphthacenylene group, a picenylene group, a perylenylene group, and a pentacenylene group, each of which is substituted with at least one of a heteroarylalkyl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic hetero-condensed polycyclic group.
[0076] In formula 201, xa and xb are each independently an integer from 0 to 5, or 0, 1, or 2. For example, xa can be 1 and xb can be 0, but is not limited thereto.
[0077] In the chemical formulas 201 and 202, R 101 ~R 108 , R 111 ~R 119 , and R 121 ~R 124 are independent of each other, Hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphate group or salt thereof, C 1 -C 10 Alkyl groups (e.g., methyl, ethyl, propyl, butyl, pentyl, hexyl, etc.) and C1-C10 alkoxy groups (e.g., methoxy, ethoxy, propoxy, butoxy, pentoxy, etc.); C substituted with one or more of deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, and a phosphate group or a salt thereof 1 -C 10 Alkyl groups and C 1 -C 10 Alkoxy groups, Phenyl, naphthyl, anthracenyl, fluorenyl and pyrenyl groups; and Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphate group or salt thereof, C 1 -C 10 Alkyl groups and C 1 -C 10 Also selected from, but not limited to, phenyl, naphthyl, anthracenyl, fluorenyl and pyrenyl groups substituted with one or more of alkoxy groups.
[0078] In the formula 201, R 109 teeth, Phenyl, naphthyl, anthracenyl and pyridinyl groups, and Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphate group or salt thereof, C 1 -C 20 Alkyl group, C 1 -C 20 It may also be selected from phenyl, naphthyl, anthracenyl, and pyridinyl groups substituted with one or more of alkoxy, phenyl, naphthyl, anthracenyl, and pyridinyl groups.
[0079] According to an embodiment, the compound represented by formula 201 may also be represented by, but is not limited to, formula 201A shown below. [ka] In the formula 201A, R 101 , R 111 , R 112 and R 109 For a detailed description of this, please refer to the above.
[0080] For example, the compound represented by chemical formula 201 and the compound represented by chemical formula 202 may include compounds HT1 to HT20 shown below, but are not limited thereto. TIFF0007594622000040.tif108152TIFF0007594622000041.tif112152TIFF0007594622000042.tif94152TIFF0007594622000043.tif103152
[0081] The thickness of the hole transport region can be from about 100 Å to about 10,000 Å, for example, from about 100 Å to about 1,000 Å. If the hole transport region includes both a hole injection layer and a hole transport layer, the thickness of the hole injection layer is about 100 Å to about 10,000 Å, for example, about 100 Å to about 1,000 Å, and the thickness of the hole transport layer is about 50 Å to about 2,000 Å, for example, about 100 Å to about 1,500 Å. When the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within the above-mentioned ranges, satisfactory hole transport properties can be obtained without a substantial increase in driving voltage.
[0082] In addition to the materials described above, the hole transport region may further include a charge generating material to enhance electrical conductivity. The charge generating material may be uniformly or non-uniformly distributed within the hole transport region. The charge generating material can be, for example, a p-dopant. The p-dopant may be one of, but is not limited to, quinone derivatives, metal oxides, and cyano group-containing compounds.
[0083] For example, non-limiting examples of p-dopants include quinone derivatives such as tetracyanoquinone dimethane (TCNQ) and 2,3,5,6-tetrafluoro-tetracyano-1,4-benzoquinone dimethane (F4-TCNQ), metal oxides such as tungsten oxide and molybdenum oxide, and cyano group-containing compounds such as compound HT-D1 shown below, but are not limited thereto. TIFF0007594622000044.tif70128TIFF0007594622000045.tif44128
[0084] The hole transport region may further include a buffer layer. The buffer layer compensates for the optical resonance distance according to the wavelength of light emitted from the light emitting layer, thereby increasing efficiency. On top of the hole transport region, an emission layer (EML) can be formed using a method such as vacuum deposition, spin coating, casting, or the LB method. When the light-emitting layer is formed by vacuum deposition or spin coating, the deposition and coating conditions vary depending on the compound used, but are generally selected from approximately the same range of conditions as those for forming the hole-injection layer. On the other hand, when the hole transport region includes an electron blocking layer, the material of the electron blocking layer is selected from among the materials used in the hole transport region as described above and the host materials described below, but is not limited thereto.
[0085] For example, when the hole transport region includes an electron blocking layer, mCP, which will be described later, can be used as the electron blocking layer material. The light-emitting layer may include a host and a dopant, where the dopant includes an organometallic compound represented by Chemical Formula 1. The host may include at least one of TPBi, TBADN, ADN (also referred to as "DNA"), CBP, CDBP, TCP, Mcp, compound H50, and compound H51 shown below. TIFF0007594622000046.tif81163TIFF0007594622000047.tif31128TIFF0007594622000048.tif35128TIFF0007594622000049.tif35128
[0086] Alternatively, the host may further include a compound represented by Formula 301 shown below. [ka] In the formula 301, Ar 111 and Ar 112 are independent of each other, Phenylene, naphthylene, phenanthrenylene, and pyrenylene groups, and It is selected from phenylene, naphthylene, phenanthrenylene, and pyrenylene groups substituted with one or more of phenyl, naphthyl, and anthracenyl groups.
[0087] In the formula 301, Ar 113 ~Ar 116 are independent of each other, C 1 -C 10 Alkyl groups, phenyl groups, naphthyl groups, phenanthrenyl groups, and pyrenyl groups, and It is selected from phenyl, naphthyl, phenanthrenyl, and pyrenyl groups substituted with one or more of phenyl, naphthyl, and anthracenyl groups. In formula 301, g, h, i, and j are each independently an integer from 0 to 4, for example, 0, 1, or 2.
[0088] In the formula 301, Ar 113 ~Ar 116 are independent of each other, C substituted with one or more of phenyl, naphthyl, and anthracenyl groups 1 -C 10 Alkyl groups, A phenyl group, a naphthyl group, an anthracenyl group, a pyrenyl group, a phenanthrenyl group, and a fluorenyl group, Deuterium, -F, -Cl, -Br, -I, hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphate group or salt thereof, C 1 -C 60 Alkyl group, C 2 -C 60 Alkenyl group, C 2 -C 60 Alkynyl group, C 1 -C 60 phenyl, naphthyl, anthracenyl, pyrenyl, phenanthrenyl, and fluorenyl groups substituted with one or more of alkoxy, phenyl, naphthyl, anthracenyl, pyrenyl, phenanthrenyl, and fluorenyl groups; and TIFF0007594622000051.tif28128, but is not limited thereto.
[0089] Alternatively, the host may include a compound represented by formula 302, shown below. [ka] In the formula 302, Ar 122 ~Ar125 For a detailed description, see Ar of formula 301. 113 Please refer to the explanation about. In the formula 302, Ar 126 and Ar 127 are independent of each other, C 1 -C 10 It may also be an alkyl group, for example a methyl group, an ethyl group or a propyl group. In formula 302, k and l are each independently an integer from 0 to 4. For example, k and l are each 0, 1, or 2.
[0090] The compound represented by chemical formula 301 and the compound represented by chemical formula 302 may include, but are not limited to, compounds H1 to H42 shown below. TIFF0007594622000053.tif103154TIFF0007594622000054.tif104157TIFF0007594622000055.tif10415 7TIFF0007594622000056.tif81160TIFF0007594622000057.tif75160TIFF0007594622000058.tif106152
[0091] When the organic light emitting device is a full-color organic light emitting device, the light emitting layer is patterned into a red light emitting layer, a green light emitting layer, and a blue light emitting layer. Alternatively, the light emitting layer may have a structure in which a red light emitting layer, a green light emitting layer, and / or a blue light emitting layer are stacked to emit white light. When the light-emitting layer contains a host and a dopant, the content of the dopant is generally selected from the range of about 0.01 to about 15 parts by weight based on about 100 parts by weight of the host, but is not limited thereto. The thickness of the light-emitting layer is from about 100 Å to about 1,000 Å, for example, from about 200 Å to about 600 Å. When the thickness of the light-emitting layer satisfies the above range, excellent light-emitting characteristics can be exhibited without a substantial increase in driving voltage.
[0092] An electron transport region is then deposited on top of the light emitting layer. The electron transport region may include at least one of a hole blocking layer, an electron transport layer, and an electron injection layer. For example, the electron transport region can have a structure of hole blocking layer / electron transport layer / electron injection layer, or electron transport layer / electron injection layer, but is not limited thereto. The electron transport layer can have a single layer or a multi-layer structure comprising two or more different materials. The conditions for forming the hole blocking layer, the electron transport layer and the electron injection layer in the electron transport region refer to the conditions for forming the hole injection layer.
[0093] When the electron transport region includes a hole blocking layer, the hole blocking layer may include at least one of, for example, but not limited to, BCP, Bphen, and BAlq shown below. The thickness of the hole blocking layer is from about 20 Å to about 1,000 Å, for example, from about 30 Å to about 300 Å. When the thickness of the hole blocking layer satisfies the above range, excellent hole blocking properties can be obtained without a substantial increase in driving voltage.
[0094] The electron transport layer may further comprise BCP, Bphen, and at least one of Alq3, Balq, TAZ, and NTAZ shown below. TIFF0007594622000060.tif69152 Alternatively, the electron transport layer may contain at least one of the compounds ET1 and ET2 shown below, but is not limited thereto. The thickness of the electron transport layer is from about 100 Å to about 1,000 Å, for example, from about 150 Å to about 500 Å. When the thickness of the electron transport layer satisfies the above-mentioned range, satisfactory electron transport properties can be obtained without a substantial increase in driving voltage.
[0095] The electron transport layer may further include a metal-containing material in addition to the materials described above. The metal-containing material may include a Li complex. The Li complex may include, for example, the compound ET-D1 (lithium quinolate (LiQ)) or ET-D2 shown below. TIFF0007594622000062.tif65128
[0096] The electron transport region may also include an electron injection layer (EIL) to facilitate electron injection from the second electrode 19. The electron injection layer is LiF, NaCl, CsF, Li 2 At least one selected from the group consisting of O and BaO may be included. The thickness of the electron injection layer is from about 1 Å to about 100 Å, or from about 3 Å to about 90 Å. When the thickness of the electron injection layer satisfies the above-mentioned range, satisfactory electron injection characteristics can be obtained without a substantial increase in driving voltage.
[0097] On top of the organic layer 15, a second electrode 19 is provided. The second electrode 19 is also the cathode. Materials for the second electrode 19 can include metals, alloys, electrically conductive compounds, and combinations thereof that have relatively low work functions. Specific examples of materials that can be used to form the second electrode 19 include lithium (Li), magnesium (Mg), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), magnesium-silver (Mg-Ag), etc. Alternatively, in order to obtain a front light emitting element, the transmissive second electrode 19 can be formed using ITO or IZO. Various modifications are possible. Although the organic light-emitting device has been described above with reference to FIG. 1, the present invention is not limited thereto.
[0098] In this specification, C 1 -C 60The alkyl group means a linear or branched aliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms, and specific examples include a methyl group, an ethyl group, a propyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl group, an iso-amyl group, and a hexyl group. In this specification, C 1 -C 60 The alkylene group is C 1 -C 60 It refers to a divalent group having the same structure as an alkyl group. In this specification, C 1 -C 60 The alkoxy group is -OA. 101 (Here, A 101 is C 1 -C 60 Specific examples of the aryl group include methoxy, ethoxy, and isopropyloxy groups.
[0099] In this specification, C 2 -C 60 The alkenyl group is C 2 -C 60 It has a structure containing one or more carbon double bonds at the middle or end of the alkyl group, and specific examples thereof include an ethenyl group, a propenyl group, and a butenyl group. In this specification, C 2 -C 60 The alkenylene group is C 2 -C 60 It means a divalent group having the same structure as an alkenyl group. In this specification, C 2 -C 60 The alkynyl group is C 2 -C 60 It has a structure containing one or more carbon triple bonds in the middle or at the end of the alkyl group, and specific examples thereof include an ethynyl group and a propynyl group. In this specification, C 2 -C 60 The alkynylene group is C 2 -C60 It means a divalent group having the same structure as an alkynyl group.
[0100] In this specification, C 3 -C 10 The cycloalkyl group means a monovalent saturated hydrocarbon monocyclic group having 3 to 10 carbon atoms, and specific examples thereof include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, and a cycloheptyl group. In this specification, C 3 -C 10 The cycloalkylene group is C 3 -C 10 It means a divalent group having the same structure as a cycloalkyl group. In this specification, C 1 -C 10 The heterocycloalkyl group means a monovalent monocyclic group having 1 to 10 carbon atoms containing at least one heteroatom selected from N, O, P, and S as a ring-forming atom, and specific examples thereof include a tetrahydrofuranyl group, a tetrahydrothiophenyl group, and the like. In this specification, C 1 -C 10 The heterocycloalkylene group is 1 -C 10 It means a divalent group having the same structure as a heterocycloalkyl group.
[0101] In this specification, C 3 -C 10 The cycloalkenyl group refers to a monovalent monocyclic group having 3 to 10 carbon atoms, which has at least one double bond in the ring but does not have aromaticity. Specific examples thereof include a cyclopentenyl group, a cyclohexenyl group, and a cycloheptenyl group. In this specification, C 3 -C 10 The cycloalkenylene group is C 3 -C 10 It means a divalent group having the same structure as a cycloalkenyl group. In this specification, C 1 -C 10The heterocycloalkenyl group is a monovalent monocyclic group having 1 to 10 carbon atoms and containing at least one heteroatom selected from N, O, P, and S as a ring-forming atom, and has at least one double bond in the ring. C 1 -C 10 Specific examples of heterocycloalkenyl groups include a 2,3-hydrofuranyl group, a 2,3-hydrothiophenyl group, and the like. In this specification, C 1 -C 10 The heterocycloalkenylene group is C 1 -C 10 It means a divalent group having the same structure as a heterocycloalkenyl group.
[0102] In this specification, C 6 -C 60 An aryl group means a monovalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms, C 6 -C 60 An arylene group refers to a divalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms. C 6 -C 60 Specific examples of the aryl group include a phenyl group, a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, and a chrysenyl group. C 6 -C 60 Aryl groups and C 6 -C 60 When an arylene group contains two or more rings, the two or more rings are fused together.
[0103] In this specification, C 1 -C 60 The heteroaryl group means a monovalent group having a carbocyclic aromatic system having 1 to 60 carbon atoms and containing at least one heteroatom selected from N, O, P, and S as a ring-forming atom, and C 1 -C 60 The heteroarylene group means a divalent group containing at least one heteroatom selected from N, O, P, and S as a ring-forming atom and having a carbocyclic aromatic system having 1 to 60 carbon atoms. C 1 -C 60 Specific examples of the heteroaryl group include a pyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinyl group, a triazinyl group, a quinolinyl group, an isoquinolinyl group, and the like. C 1 -C 60 Heteroaryl groups and C 1 -C 60 When a heteroarylene group contains more than one ring, the two or more rings are fused together.
[0104] In this specification, C 6 -C 60 The aryloxy group is -OA. 102 (Here, A 102 is C 6 -C 60 aryl group), C 6 -C 60 The arylthio group is -SA 103 (Here, A 103 is C 6 -C 60 aryl group). In this specification, C 7 -C 60 The arylalkyl group is -A 104 A 105 (Here, A 104 is C 6 -C 59 is an aryl group, 105 is C 1 -C 53 (an alkyl group). In this specification, C 2 -C 60 The heteroaryloxy group is -OA. 106 (Here, A 106 is C 2 -C 60 A heteroaryl group is represented herein. 2 -C 60 The heteroarylthio group is -SA 107 (Here, A 107 is C 2 -C 60A heteroaryl group is represented herein. 3 -C 60 The heteroarylalkyl group is -A 108 A 109 (Here, A 108 is C 2 -C 59 A is a heteroaryl group; 109 is C 1 -C 58 (an alkyl group).
[0105] As used herein, the term "monovalent non-aromatic condensed polycyclic group" refers to a monovalent group (e.g., having 8 to 60 carbon atoms) in which two or more rings are condensed with each other, containing only carbon as ring-forming atoms, and having non-aromaticity as a whole molecule. Specific examples of monovalent non-aromatic condensed polycyclic groups include a fluorenyl group. In this specification, a divalent non-aromatic condensed polycyclic group means a divalent group having the same structure as a monovalent non-aromatic condensed polycyclic group.
[0106] As used herein, the term "non-aromatic condensed heteropolycyclic group" refers to a monovalent group (e.g., having 1 to 60 carbon atoms) in which two or more rings are condensed with each other and which contains, in addition to carbon, a heteroatom selected from N, O, P, and S as ring-forming atoms, and in which the entire molecule has non-aromaticity. Examples of the monovalent non-aromatic condensed heteropolycyclic group include a carbazolyl group. In this specification, a divalent non-aromatic condensed heteropolycyclic group means a divalent group having the same structure as a monovalent non-aromatic condensed heteropolycyclic group.
[0107] As used herein, substituted C 1 -C 60 Alkyl groups, substituted C 2 -C 60 Alkenyl groups, substituted C2 -C 60 Alkynyl groups, substituted C 1 -C 60 Alkoxy groups, substituted C 3 -C 10 Cycloalkyl groups, substituted C 1 -C 10 Heterocycloalkyl groups, substituted C 3 -C 10 Cycloalkenyl groups, substituted C 1 -C 10 Heterocycloalkenyl Groups, Substituted C 6 -C 60 Aryl groups, substituted C 6 -C 60 Aryloxy groups, substituted C 6 -C 60 Arylthio groups, substituted C 7 -C 60 Arylalkyl groups, substituted C 1 -C 60 Heteroaryl Groups, Substituted C 1 -C 60 Heteroaryloxy groups, substituted C 1 -C 60 Heteroarylthio groups, substituted C 2 -C 60 At least one of the substituents of the heteroarylalkyl group, the substituted monovalent non-aromatic fused polycyclic group, and the substituted monovalent non-aromatic fused polycyclic heterocyclic group is Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 60 Alkyl group, C 2 -C 60 Alkenyl group, C 2 -C 60 Alkynyl groups, and C 1 -C60 Alkoxy groups, Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 3 -C 10 Cycloalkyl groups, C 1 -C 10 Heterocycloalkyl groups, C 3 -C 10 Cycloalkenyl group, C 1 -C 10 Heterocycloalkenyl group, C 6 -C 60 Aryl group, C 6 -C 60 Aryloxy group, C 6 -C 60 Arylthio group, C 7 -C 60 Arylalkyl groups, C 1 -C 60 Heteroaryl groups, C 1 -C 60 Heteroaryloxy group, C 1 -C 60 Heteroarylthio groups, C 2 -C 60 C substituted with at least one of a heteroarylalkyl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed polycyclic heterocyclic group; 1 -C 60 Alkyl group, C 2 -C 60 Alkenyl group, C 2 -C 60 Alkynyl groups and C 1 -C 60 Alkoxy groups, C 3 -C 10 Cycloalkyl groups, C 1 -C 10 Heterocycloalkyl groups, C 3-C 10 Cycloalkenyl group, C 1 -C 10 Heterocycloalkenyl group, C 6 -C 60 Aryl group, C 6 -C 60 Aryloxy group, C 6 -C 60 Arylthio group, C 7 -C 60 Arylalkyl groups, C 1 -C 60 Heteroaryl groups, C 1 -C 60 Heteroaryloxy group, C 1 -C 60 Heteroarylthio groups, C 2 -C 60 heteroarylalkyl groups, monovalent non-aromatic condensed polycyclic groups, and monovalent non-aromatic condensed heteropolycyclic groups; Deuterium, -F, -Cl, -Br, -I, -CD 3 , -CD 2 H, -CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl group, cyano group, nitro group, amino group, amidino group, hydrazine group, hydrazone group, carboxylic acid group or a salt thereof, sulfonic acid group or a salt thereof, phosphoric acid group or a salt thereof, C 1 -C 60 Alkyl group, C 2 -C 60 Alkenyl group, C 2 -C 60 Alkynyl group, C 1 -C 60 Alkoxy group, C 3 -C 10 Cycloalkyl groups, C 1 -C 10 Heterocycloalkyl groups, C 3 -C 10 Cycloalkenyl group, C 1 -C 10 Heterocycloalkenyl group, C 6 -C 60 Aryl group, C 6 -C 60 Aryloxy group, C6 -C 60 Arylthio group, C 7 -C 60 Arylalkyl groups, C 1 -C 60 Heteroaryl groups, C 1 -C 60 Heteroaryloxy group, C 1 -C 60 Heteroarylthio groups, C 2 -C 60 C substituted with at least one of a heteroarylalkyl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed polycyclic heterocyclic group; 3 -C 10 Cycloalkyl groups, C 1 -C 10 Heterocycloalkyl groups, C 3 -C 10 Cycloalkenyl group, C 1 -C 10 Heterocycloalkenyl group, C 6 -C 60 Aryl group, C 6 -C 60 Aryloxy group, C 6 -C 60 Arylthio group, C 7 -C 60 Arylalkyl groups, C 1 -C 60 Heteroaryl groups, C 1 -C 60 Heteroaryloxy group, C 1 -C 60 Heteroarylthio groups, C 2 -C 60 heteroarylalkyl groups, monovalent non-aromatic condensed polycyclic groups, and monovalent non-aromatic condensed heteropolycyclic groups, and -C(=O)(Q 11 ), -Si(Q 11 )(Q 12 )(Q 13 ) and -N(Q 11 )(Q 12 ), Q 11 ~Q 13are each independently hydrogen, deuterium, -F, -Cl, -Br, -I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C 1 -C 60 Alkyl groups, substituted or unsubstituted C 2 -C 60 Alkenyl groups, substituted or unsubstituted C 2 -C 60 Alkynyl groups, substituted or unsubstituted C 1 -C 60 Alkoxy groups, substituted or unsubstituted C 3 -C 10 Cycloalkyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkyl groups, substituted or unsubstituted C 3 -C 10 Cycloalkenyl groups, substituted or unsubstituted C 1 -C 10 Heterocycloalkenyl groups, substituted or unsubstituted C 6 -C 60 Aryl groups, substituted or unsubstituted C 6 -C 60 Aryloxy groups, substituted or unsubstituted C 6 -C 60 Arylthio groups, substituted or unsubstituted C 7 -C 60 Arylalkyl groups, substituted or unsubstituted C 1 -C 60 Heteroaryl groups, substituted or unsubstituted C 1 -C 60 Heteroaryloxy groups, substituted or unsubstituted C 1 -C 60 Heteroarylthio groups, substituted or unsubstituted C 2 -C 60 It is selected from among a heteroarylalkyl group, a substituted or unsubstituted monovalent non-aromatic fused polycyclic group, and a substituted or unsubstituted monovalent non-aromatic fused polycyclic heterocyclic group.
[0108] When a group containing a specific number of carbon atoms is substituted with any of the groups listed in the preceding paragraph, the number of carbon atoms in the resulting substituted group is defined as the sum of the number of carbon atoms contained in the original (unsubstituted) group and the number of carbon atoms contained in the substituent (if any). For example, the replaced C 1 -C 60 The alkyl group is C 6 -C 60 Aryl-substituted C 1 -C 60 When referring to an alkyl group, the total number of carbon atoms in the resulting aryl-substituted alkyl group is C 7 -C 120 It is.
[0109] Hereinafter, the compound and the organic light-emitting device according to one embodiment of the present invention will be described in more detail with reference to synthesis examples and examples. However, the present invention is not limited to the following synthesis examples and examples. In the synthesis examples below, the expression "'B' was used in place of 'A'" means that the amount of 'B' used and the amount of 'A' used are the same on a molar equivalent basis.
[0110] Example <Synthesis Example 1: Synthesis of Compound 3> TIFF0007594622000063.tif129146
[0111] 1) Synthesis of "I-3-2" To the reactor was added 15.0 g (74.7 mmol) of 3-bromophenylboronic acid, 165 ml of toluene, and 60 ml of ethyl alcohol. To this, 13.2 g (57.5 mmol) of 2-bromo-5-(trimethylsilyl)pyridine, Pd(PPh 3 ) 4 After adding 4.6 g (4.02 mmol) and 60 ml of 2.0 M sodium carbonate solution, the mixture was heated to reflux at 110° C. for 18 hours. After the reaction was completed, the mixture was concentrated under reduced pressure, dissolved in 400 ml of dichloromethane, and filtered through diatomite. The obtained organic layer was dried over magnesium sulfate, distilled under reduced pressure, and purified by liquid chromatography to obtain 14.2 g (46 mmol, yield 80%) of intermediate "I-3-2". LC-MS(liquid chromatography-mass spectrometry)m / z=306(M+H) +
[0112] 2) Synthesis of intermediate "I-3-1" To a reactor, 8.5 g (27.6 mmol) of intermediate "I-3-2" and 250 ml of toluene were added. Here, 1.56 ml (11.1 mmol) of 2,4,6-trimethylaniline, Pd(dba) 2 1.0 g (1.7 mmol) and P(t-Bu) 3 After adding 1.3 g (3.3 mmol) of toluene and 3.2 g (33.1 mmol) of sodium butoxide, the mixture was heated to reflux at 120° C. for 24 hours. After the reaction was completed, the mixture was concentrated under reduced pressure, dissolved in 400 ml of dichloromethane, and filtered through diatomaceous earth. The obtained organic layer was dried over magnesium sulfate, distilled under reduced pressure, and purified by liquid chromatography to obtain 4 g (11 mmol, yield 99%) of intermediate "I-3-1". LC-MS m / z=586(M+H) +
[0113] 3) Synthesis of "Compound 3" At 25° C., 1.5 g (2.5 mmol) of intermediate “I-3-1”, 100 ml of o-xylene, and 20 ml of benzonitrile were added to a reactor. Here, PtCl 2 (NCPh) 2 After adding 1.2 g (2.5 mmol), the mixture was heated under reflux for 26 hours. After the reaction was completed, the mixture was concentrated under reduced pressure and purified by liquid chromatography to obtain 0.7 g (0.8 mmol, yield 30%) of “Compound 3”. The compounds produced were analyzed by LCMS and 1This was confirmed by H NMR (nuclear magnetic resonance). LC-MS m / z=779(M+H) + 1 H NMR (300 mHz, CDCl 3 )δ=8.96(s,2H), 7.94-7.92(m,4H), 7.38(d,2H), 7.10(s,2H), 7.03(t,2H), 6.28-6.26(m,2H), 2.43(s,3H), 1.89(s,6H), 0.41(s,18H)
[0114] <Synthesis Example 2: Synthesis of Compound 1> TIFF0007594622000064.tif57156
[0115] 1) Synthesis of intermediate "I-1-1" Intermediate "I-1-1 (yield 76%)" was synthesized using the same method as that for intermediate "I-3-1" in Synthesis Example 1, except that aniline was used instead of 2,4,6-trimethylaniline. The produced compound was confirmed by LC-MS. LC-MS m / z=544(M+H) +
[0116] 2) Synthesis of "Compound 1" "Compound 1" (yield 32%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-1-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=737(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.92(s,2H), 7.90-7.86(m,4H), 7.42(d,2H), 7.31-7.22(m,4H), 7.18-7.09(m,3H), 6.25-6.23(m,2H), 0.44(s,18H)
[0117] <Synthesis Example 3: Synthesis of Compound 2> TIFF0007594622000065.tif105147
[0118] 1) Synthesis of intermediate "I-2-3" 10.6 g (42.2 mmol) of 2,5-dibromo-3-methylpyridine was dissolved in 200 ml of diethyl ether, and then 27.0 ml of n-BuLi (1.6 M solution in hexane) was gradually added at −78° C. and stirred for about 2 hours. Thereafter, 6.5 ml (50.6 mmol) of chlorotrimethylsilane was gradually added, and the mixture was stirred at −78° C. for 1 hour, and then stirred at room temperature for 16 hours. After the reaction was completed, 200 ml of ethyl acetate and 300 ml of distilled water were added for extraction, and the organic layer was dried over magnesium sulfate and distilled under reduced pressure. The resulting product was separated and purified by column chromatography to obtain about 8.7 g (35.9 mmol, 85% yield) of intermediate "I-2-3". The produced compound was confirmed by LC-MS. LC-MS m / z=244(M+H) +
[0119] 2) Synthesis of intermediate "I-2-2" Intermediate "I-2-2" (yield 80%) was synthesized using the same method as that for intermediate "I-3-2" in Synthesis Example 1, except that intermediate "I-2-3" was used instead of 2-bromo-5-(trimethylsilyl)pyridine. The produced compound was confirmed by LC-MS. LC-MS m / z=320(M+H) +
[0120] 3) Synthesis of intermediate "I-2-1" Intermediate "I-2-1" (yield 70%) was synthesized using the same method as for synthesizing intermediate "I-3-1" in Synthesis Example 1, except that intermediate "I-2-2" was used instead of intermediate "I-3-2". The produced compound was confirmed by LC-MS. LC-MS m / z=320(M+H) +
[0121] 4) Synthesis of "Compound 2" "Compound 2" (yield 45%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-2-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=807(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.88(s,2H), 7.86-7.82(m,4H), 7.47-7.41(m,2H), 7.16-7.11(m,2H), 6.78(brs,2H), 2.36(s,6H), 2.22(s,3H), 2.09(s,6H)
[0122] <Synthesis Example 4: Synthesis of Compound 4> TIFF0007594622000066.tif99147
[0123] 1) Synthesis of intermediate "I-4-3" 5.0 g (20.5 mmol) of intermediate "I-2-3" was dissolved in 300 ml of tetrahydrofuran, and then 18.0 ml of lithium diisopropylamide (LDA) (2.0 M solution in tetrahydrofuran (THF)) was gradually added at -78°C and stirred for about 1 hour. After that, the mixture was stirred at room temperature for about 2 hours, cooled again to -78°C, and 3.8 ml (41.0 mmol) of 2-bromopropane was gradually added thereto, followed by stirring at -78°C for 1 hour and then at room temperature for about 18 hours. After the reaction was completed, 200 ml of ethyl acetate and 300 ml of distilled water were added for extraction, and the organic layer was dried over magnesium sulfate and distilled under reduced pressure. The resulting product was purified by column chromatography to obtain about 2.9 g (10.4 mmol, 50% yield) of intermediate "I-4-3". The compound produced was confirmed by LC-MS. LC-MS m / z=286(M+H) +
[0124] 2) Synthesis of intermediate "I-4-2" Intermediate "I-4-2" (yield 65%) was synthesized using the same method as that for intermediate "I-3-2" in Synthesis Example 1, except that intermediate "I-4-3" was used instead of 2-bromo-5-(trimethylsilyl)pyridine. The produced compound was confirmed by LC-MS. LC-MS m / z=362(M+H) +
[0125] 3) Synthesis of intermediate "I-4-1" Intermediate "I-4-1" (yield 67%) was synthesized using the same method as for synthesizing intermediate "I-3-1" in Synthesis Example 1, except that intermediate "I-4-2" was used instead of intermediate "I-3-2". The produced compound was confirmed by LC-MS. LC-MS m / z=698(M+H) +
[0126] 4) Synthesis of "Compound 4" "Compound 4" (yield 28%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-4-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=891(M+H) + 1 H NMR (300 MHz, CDCl 3)δ=8.91(s,2H), 7.88-7.84(m,4H), 7.50-7.45(m,2H), 7.27-7.22(m,2H), 6.74(brs ,2H), 3.15-3.11(m,4H), 2.28(s,3H), 2.11(s,6H), 1.88-1.85(m,2H), 0.91(d,12H)
[0127] <Synthesis Example 5: Synthesis of Compound 5> TIFF0007594622000067.tif104143
[0128] 1) Synthesis of intermediate I-5-3 Intermediate "I-5-3" (yield 60%) was synthesized using the same method as that for intermediate "I-2-3" in Synthesis Example 3, except that chlorotriethylsilane was used instead of chlorotrimethylsilane. The produced compound was confirmed by LC-MS. LC-MS m / z=272(M+H) +
[0129] 2) Synthesis of intermediate "I-5-2" Intermediate "I-5-2" (yield 80%) was synthesized using the same method as for synthesizing intermediate "I-2-2" in Synthesis Example 3, except that intermediate "I-5-3" was used instead of intermediate "I-2-3". The produced compound was confirmed by LC-MS. LC-MS m / z=348(M+H) +
[0130] 3) Synthesis of intermediate "I-5-1" Intermediate "I-5-1" (yield 57%) was synthesized using the same method as for synthesizing intermediate "I-2-1" in Synthesis Example 3, except that intermediate "I-5-2" was used instead of intermediate "I-2-2". The produced compound was confirmed by LC-MS. LC-MS m / z=628(M+H) +
[0131] 4) Synthesis of "Compound 5" "Compound 5" (yield 35%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-5-1" was used instead of intermediate "I-2-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=821(M+H) + 1 H NMR (300 mHz, CDCl 3 )δ=8.98(s,2H), 7.98-7.93(m,4H), 7.36(d,2H), 7.12(s,2H), 7.08-7.04(m,2H), 6.25-6.23(m,2H), 2.33(s,3H), 1.93(s,6H), 1.01-0.94(m,18H), 0.76(brs,12H)
[0132] <Synthesis Example 6: Synthesis of Compound 6> TIFF0007594622000068.tif98143
[0133] 1) Synthesis of intermediate "I-6-3" Intermediate "I-6-3" (yield 75%) was synthesized using the same method as that for intermediate "I-5-3" in Synthesis Example 5, except that chlorotriphenylsilane was used instead of chlorotrimethylsilane. The produced compound was confirmed by LC-MS. LC-MS m / z=416(M+H) +
[0134] 2) Synthesis of intermediate "I-6-2" Intermediate "I-6-2" (yield 73%) was synthesized using the same method as for synthesizing intermediate "I-5-2" in Synthesis Example 5, except that intermediate "I-6-3" was used instead of intermediate "I-5-3". The produced compound was confirmed by LC-MS. LC-MS m / z=492(M+H) +
[0135] 3) Synthesis of intermediate "I-6-1" Intermediate "I-6-1" (yield 60%) was synthesized using the same method as for synthesizing intermediate "I-5-1" in Synthesis Example 5, except that intermediate "I-6-2" was used instead of intermediate "I-5-2" and 2,5-dimethylaniline was used instead of 2,4,6-trimethylaniline. The produced compound was confirmed by LC-MS. LC-MS m / z=944(M+H) +
[0136] 4) Synthesis of "Compound 6" "Compound 6" (yield 30%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-6-1" was used instead of intermediate "I-2-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=1137(M+H) + 1 H NMR (300 mHz, CDCl 3 )δ=8.85(s,2H), 7.95-7.91(m,2H), 7.88-7.73(m,4H), 7.58-7.22(m,32H), 7.14(s,2H), 7.04(s,1H), 2.31(s,6H)
[0137] <Synthesis Example 7: Synthesis of Compound 7> TIFF0007594622000069.tif49143
[0138] 1) Synthesis of intermediate "I-7-1" Intermediate "I-7-1" (yield 85%) was synthesized using the same method as that for intermediate "I-3-1" in Synthesis Example 1, except that 1-naphthylaniline was used instead of 2,4,6-trimethylaniline. The produced compound was confirmed by LC-MS. LC-MS m / z=594(M+H) +
[0139] 2) Synthesis of "Compound 7" "Compound 7" (yield 40%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-7-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=787(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.82(s,2H), 8.27-8.19(m,2H), 7.85-7.79(m,4H), 7.72-7.45(m,8H), 6.98-6.94(m,2H), 0.38(s,18H)
[0140] <Synthesis Example 8: Synthesis of Compound 8> TIFF0007594622000070.tif56143
[0141] 1) Synthesis of intermediate "I-8-1" Intermediate "I-8-1" (yield 70%) was synthesized using the same method as that for intermediate "I-3-1" in Synthesis Example 1, except that 3-amino-biphenyl was used instead of 2,4,6-trimethylaniline. The produced compound was confirmed by LC-MS. LC-MS m / z=620(M+H) +
[0142] 2) Synthesis of "Compound 8" "Compound 8" (yield 25%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-8-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=813(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.78(s,2H), 7.82-7.65(m,8H), 7.55-7.41(m,6H), 7.28-7.22(m,3H), 7.17-7.12(m,2H), 0.36(s,18H)
[0143] <Synthesis Example 9: Synthesis of Compound 9> TIFF0007594622000071.tif105143
[0144] 1) Synthesis of intermediate "I-9-2" Intermediate "I-9-1" (yield 75%) was synthesized using the same method as that for intermediate "I-3-2" in Synthesis Example 1, except that 3-bromo-5-methylphenylboronic acid was used instead of 3-bromophenylboronic acid. The produced compound was confirmed by LC-MS. LC-MS m / z=320(M+H) +
[0145] 2) Synthesis of intermediate "I-9-1" Intermediate "I-9-1" (yield 53%) was synthesized using the same method as for synthesizing intermediate "I-3-1" in Synthesis Example 1, except that intermediate "I-9-2" was used instead of intermediate "I-3-2". The produced compound was confirmed by LC-MS. LC-MS m / z=614(M+H) +
[0146] 3) Synthesis of "Compound 9" "Compound 9" (yield 14%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-9-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=807(M+H) + 1H NMR (300 MHz, CDCl 3 )δ=8.85(s,2H), 7.86-7.60(m,4H), 7.51(brs,2), 7.38(brs,2H), 6.82(s,2H), 2.28(s,6H), 2.21(s,3H), 2.09(s,6H), 0.35(s,18H)
[0147] <Synthesis Example 10: Synthesis of Compound 10> TIFF0007594622000072.tif94139
[0148] 1) Synthesis of intermediate "I-10-3" Intermediate "I-10-3" (yield 60%) was synthesized using the same method as that for intermediate "I-2-3" in Synthesis Example 3, except that 2,4-dibromopyridine was used instead of 2,5-dibromo-3-methylpyridine. The produced compound was confirmed by LC-MS. LC-MS m / z=230(M+H) +
[0149] 2) Synthesis of intermediate "I-10-2" Intermediate "I-10-2" (yield 70%) was synthesized using the same method as for synthesizing intermediate "I-9-2" in Synthesis Example 9, except that intermediate "I-10-3" was used instead of intermediate "I-2-3". The produced compound was confirmed by LC-MS. LC-MS m / z=306(M+H) +
[0150] 3) Synthesis of intermediate "I-10-1" Intermediate "I-10-1" (yield 64%) was synthesized using the same method as for synthesizing intermediate "I-9-1" in Synthesis Example 9, except that intermediate "I-10-2" was used instead of intermediate "I-9-2". The produced compound was confirmed by LC-MS. LC-MS m / z=586(M+H) +
[0151] 4) Synthesis of "Compound 10" "Compound 10" (yield 12%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-10-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=779(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.52(d,2H), 7.84(d,2H), 7.75(d,2H), 7.53-7.50(m,2), 7.28-7.20(m,4H), 6.84(brs,2H), 2.23(s,3H), 2.11(s,6H), 0.33(s,18H)
[0152] <Synthesis Example 11: Synthesis of Compound 11> TIFF0007594622000073.tif103153
[0153] 1) Synthesis of intermediate "I-11-3" Intermediate "I-11-3" (yield 85%) was synthesized using the same method as that for intermediate "I-6-3" in Synthesis Example 6, except that chloro(dimethyl)phenylsilane was used instead of chlorotrimethylsilane. The produced compound was confirmed by LC-MS. LC-MS m / z=292(M+H) +
[0154] 2) Synthesis of intermediate "I-11-2" Intermediate "I-11-2" (yield 75%) was synthesized using the same method as for synthesizing intermediate "I-6-2" in Synthesis Example 6, except that intermediate "I-11-3" was used instead of intermediate "I-6-3". The produced compound was confirmed by LC-MS. LC-MS m / z=368(M+H) +
[0155] 3) Synthesis of intermediate "I-11-1" Intermediate "I-11-1" (yield 55%) was synthesized using the same method as for synthesizing intermediate "I-6-1" in Synthesis Example 6, except that intermediate "I-11-2" was used instead of intermediate "I-6-2". The produced compound was confirmed by LC-MS. LC-MS m / z=668(M+H) +
[0156] 4) Synthesis of "Compound 11" "Compound 11" (yield 33%) was synthesized using the same method as for the synthesis of "Compound 6" in Synthesis Example 6, except that intermediate "I-11-1" was used instead of intermediate "I-6-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=861(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.89(d,2H), 7.86-7.84(m,2H), 7.80-7.71(m,2H), 7.55-7.51(m,2), 7.36-7.20(m,14H), 7.12-7.05(m,3H), 0.71(s,12H)
[0157] <Synthesis Example 12: Synthesis of Compound 12> TIFF0007594622000074.tif52152
[0158] 1) Synthesis of intermediate "I-12-2" Intermediate "I-12-2" was synthesized using the same method as that for synthesizing intermediate "I-11-3" and intermediate "I-11-2" in Synthesis Example 11, except that chloro(methyl)diphenylsilane was used instead of chlorotrimethylsilane. The produced compound was confirmed by LC-MS. LC-MS m / z=430(M+H) +
[0159] 2) Synthesis of intermediate "I-12-1" Intermediate "I-12-1" (yield 62%) was synthesized using the same method as for synthesizing intermediate "I-11-1" in Synthesis Example 11, except that intermediate "I-12-2" was used instead of intermediate "I-11-2". The compound produced was confirmed by LC-MS. LC-MS m / z=792(M+H) +
[0160] 3) Synthesis of "Compound 12" "Compound 12" (yield 20%) was synthesized using the same method as that for "Compound 11" in Synthesis Example 11, except that intermediate "I-12-1" was used instead of intermediate "I-11-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=985(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.82(brs,2H), 8.01-7.98(m,2H), 7.82-7.76(m,4H), 7.61-7.37(m,22H), 7.28-7.24(m,4H), 7.11-7.06(m,3H), 0.68(s,6H)
[0161] <Synthesis Example 13: Synthesis of Compound 13> TIFF0007594622000075.tif107152
[0162] 1) Synthesis of intermediate "I-13-3" Intermediate "I-13-3" (yield 85%) was synthesized using the same method as that for intermediate "I-10-3" in Synthesis Example 10, except that chlorotriethylgermane was used instead of chlorotrimethylsilane. The produced compound was confirmed by LC-MS. LC-MS m / z=318(M+H) +
[0163] 2) Synthesis of intermediate "I-13-2" Intermediate "I-13-2" (yield 70%) was synthesized using the same method as for synthesizing intermediate "I-10-2" in Synthesis Example 10, except that intermediate "I-13-3" was used instead of intermediate "I-10-3". The produced compound was confirmed by LC-MS. LC-MS m / z=394(M+H) +
[0164] 3) Synthesis of intermediate "I-13-1" Intermediate "I-13-1" (yield 55%) was synthesized using the same method as for synthesizing intermediate "I-10-1" in Synthesis Example 10, except that intermediate "I-13-2" was used instead of intermediate "I-10-2". The produced compound was confirmed by LC-MS. LC-MS m / z=762(M+H) +
[0165] 4) Synthesis of "Compound 13" "Compound 13" (yield 10%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-13-1" was used instead of intermediate "I-10-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=955(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.64(d,2H), 7.88(d,2H), 7.82-7.79(m,2H), 7.52(s,2H), 7.28-7.22(m,2H), 6.91(d,2H), 6.96(brs,2H), 2.26(s,3H), 2.08(s,6H), 1.04(q,12H), 0.90(t,18H)
[0166] <Synthesis Example 14: Synthesis of Compound 14> TIFF0007594622000076.tif104144
[0167] 1) Synthesis of intermediate "I-14-1" Intermediate "I-14-1" was synthesized using the same method as that for intermediates "I-13-3", "I-13-2", and "I-13-1" in Synthesis Example 13, except that chlorotrimethylgermane was used instead of chlorotriethylgermane. The produced compound was confirmed by LC-MS. LC-MS m / z=678(M+H) +
[0168] 2) Synthesis of "Compound 14" "Compound 14" (yield 15%) was synthesized using the same method as for the synthesis of "Compound 13" in Synthesis Example 13, except that intermediate "I-14-1" was used instead of intermediate "I-13-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=871(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.57(d,2H), 7.86(d,2H), 7.80-7.76(m,2H), 7.51(s,2H), 7.25(brs, 2H), 6.88(brs,2H), 6.80(s,2H), 2.23(s,3H), 2.11(s,6H), 0.83(t,18H)
[0169] <Synthesis Example 15: Synthesis of Compound 15> TIFF0007594622000077.tif107149
[0170] 1) Synthesis of intermediate "I-15-1" Intermediate "I-15-1" was synthesized using the same method as that for intermediates "I-5-3", "I-5-2", and "I-5-1" in Synthesis Example 5, except that chlorotrimethylgermane was used instead of chlorotrimethylsilane. The produced compound was confirmed by LC-MS. LC-MS m / z=678(M+H) +
[0171] 2) Synthesis of "Compound 15" "Compound 15" (yield 25%) was synthesized using the same method as that for "Compound 5" in Synthesis Example 5, except that intermediate "I-15-1" was used instead of intermediate "I-5-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=871(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.47(brs,2H), 7.84-7.78(m,4H), 7.61(brs,2H), 7.36-7.21(m,4H), 6.76(s,2H), 2.21(s,3H), 2.09(s,6H), 0.79(s,18H)
[0172] <Synthesis Example 16: Synthesis of Compound 16> TIFF0007594622000078.tif99146
[0173] 1) Synthesis of intermediate "I-16-3" Intermediate "I-16-3" (yield 55%) was synthesized using the same method as that for intermediate "I-5-3" in Synthesis Example 5, except that 5-bromo-2-chloropyrimidine was used instead of 2,5-dibromopyridine. The produced compound was confirmed by LC-MS. LC-MS m / z=187(M+H) +
[0174] 2) Synthesis of intermediate "I-16-2" Intermediate "I-16-2" (yield 75%) was synthesized using the same method as for synthesizing intermediate "I-5-2" in Synthesis Example 5, except that intermediate "I-16-3" was used instead of intermediate "I-5-3". The produced compound was confirmed by LC-MS. LC-MS m / z=307(M+H) +
[0175] 3) Synthesis of intermediate "I-16-1" Intermediate "I-16-1" (yield 80%) was synthesized using the same method as for synthesizing intermediate "I-5-1" in Synthesis Example 5, except that intermediate "I-16-2" was used instead of intermediate "I-5-2". The produced compound was confirmed by LC-MS. LC-MS m / z=588(M+H) +
[0176] 4) Synthesis of "Compound 16" At 25° C., 5.0 g (8.5 mmol) of intermediate “I-16-1” and 300 ml of acetic acid were added to a reactor. Here, K 2 PtCl 4 After adding 3.5 g (8.5 mmol), the mixture was heated under reflux for 48 hours. After the reaction was completed, the mixture was concentrated under reduced pressure and recrystallized with dichloromethane and methanol to obtain 0.5 g (0.8 mmol, yield 8%) of “Compound 16”. The produced compound was confirmed by LCMS. LC-MS m / z=781(M+H) +
[0177] <Synthesis Example 17: Synthesis of Compound 17> TIFF0007594622000079.tif53146
[0178] 1) Synthesis of intermediate "I-17-1" To the reactor was added 30.0 g (51.0 mmol) of P-SM (custom compound, Medigen, Inc., www.medi-gen.net), 600 ml of tetrahydrofuran, and 300 ml of distilled water. To this, 28.1 g (122.4 mmol) of 2-bromo-5-(trimethylsilyl)pyridine, Pd(PPh 3 ) 4 5.9g (5.1mmol) and K 2 CO 3 After adding 21.1 g (153.0 mmol), the mixture was heated to reflux at 80° C. for 18 hours. After the reaction was completed, it was extracted with 400 ml of ethyl acetate and 100 ml of distilled water. The organic layer obtained therefrom was dried over magnesium sulfate, distilled under reduced pressure, and purified by liquid chromatography to obtain 24.0 g (38 mmol, 75% yield) of intermediate "I-17-1." The produced compound was confirmed by LCMS. LC-MS m / z=635(M+H) +
[0179] 2) Synthesis of "Compound 17" "Compound 17" (yield 35%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-17-1" was used instead of intermediate "I-3-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=828(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.81(brs,2H), 8.37(brs,2H), 7.85(brs,2H), 7.72-7.58(m,4H), 7.46-7.44(m,2H), 7.42-7.32(m,10H), 0.42(s,18H)
[0180] <Synthesis Example 18: Synthesis of Compound 18> TIFF0007594622000080.tif46146
[0181] 1) Synthesis of intermediate "I-18-1" Instead of 2-bromo-5-(trimethylsilyl)pyridine, intermediate "I-2-3" was used, and intermediate "I-18-1" (yield 60%) was synthesized using the same method as that for intermediate "I-17-1" in Synthesis Example 17. The produced compound was confirmed by LC-MS. LC-MS m / z=663(M+H) +
[0182] 2) Synthesis of "Compound 18" "Compound 18" (yield 20%) was synthesized using the same method as for the synthesis of "Compound 17" in Synthesis Example 17, except that intermediate "I-18-1" was used instead of intermediate "I-17-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=856(M+H) + 1 H NMR (300 MHz, CDCl 3 )δ=8.79(brs,2H), 8.26(brs,2H), 7.88(s,2H), 7.64-7.56(m,4H), 7.46-7.38(m,10H), 2.36(s,6H), 0.77(s,18H)
[0183] Synthesis Example 19: Synthesis of Compound 20 TIFF0007594622000081.tif541471) Synthesis of intermediate "I-20-1" Instead of intermediate "I-2-3", 1-bromo-4-(trimethylsilyl)isoquinoline (custom compound, HANCHEM CO., www.hanchem.co.kr) was used, and intermediate "I-20-1" (yield 53%) was synthesized using the same method as the synthesis method of intermediate "I-18-1" in Synthesis Example 18. The produced compound was confirmed by LC-MS. LC-MS m / z=735(M+H) +
[0184] 2) Synthesis of "Compound 20" "Compound 20" (yield 10%) was synthesized using the same method as that for "Compound 17" in Synthesis Example 17, except that intermediate "I-20-1" was used instead of intermediate "I-17-1". The produced compound was confirmed by LC-MS. LC-MS m / z=927(M) +
[0185] Synthesis Example 20: Synthesis of Compound 21 TIFF0007594622000082.tif100147
[0186] 1) Synthesis of intermediate "I-21-1" Instead of intermediate "I-2-3", 1-bromo-7-(trimethylsilyl)isoquinoline (custom compound, HANCHEM CO., www.hanchem.co.kr) was used, and intermediate "I-21-1" (yield 50%) was synthesized using the same method as the synthesis method of intermediate "I-18-1" in Synthesis Example 18. The produced compound was confirmed by LC-MS. LC-MS m / z=735(M+H) +
[0187] 2) Synthesis of "Compound 21" "Compound 21" (yield 7%) was synthesized using the same method as that for "Compound 17" in Synthesis Example 17, except that intermediate "I-20-1" was used instead of intermediate "I-17-1". The produced compound was confirmed by LC-MS. LC-MS m / z=927(M) +
[0188] Synthesis Example 21: Synthesis of Compound 22 TIFF0007594622000083.tif43150
[0189] 1) Synthesis of intermediate "I-22-1" Intermediate "I-22-1" (yield 62%) was synthesized using the same method as that for intermediate "I-17-1" in Synthesis Example 17, except that P-SM2 (ordered compound, Medigen, Inc., www.medi-gen.net) was used instead of P-SM, and intermediate "I-4-3" was used instead of intermediate "I-2-3". The produced compound was confirmed by LC-MS. LC-MS m / z=581(M+H) +
[0190] 2) Synthesis of "Compound 22" "Compound 22" (yield 22%) was synthesized using the same method as for the synthesis of "Compound 17" in Synthesis Example 17, except that intermediate "I-22-1" was used instead of intermediate "I-17-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=774(M+H) + 1 H NMR (300 MHz, CDCl 3 ) δ=8.86(brs,2H), 7.95(d,2H), 7.83(brs,2H), 7.52-7.48(m,2H), 7.33- 7.25(m,2H), 3.16(d,4H), 1.96-1.93(m,2H), 1.00(d,12H), 0.41(s,18H)
[0191] Synthesis Example 22: Synthesis of Compound 23 TIFF0007594622000084.tif48152
[0192] 1) Synthesis of intermediate "I-23-1" Intermediate "I-23-1" (yield 76%) was synthesized using intermediate "I-15-3" instead of intermediate "I-2-3" and the same method as that for intermediate "I-18-1" in Synthesis Example 18. The produced compound was confirmed by LC-MS. LC-MS m / z=727(M+H) +
[0193] 2) Synthesis of "Compound 23" "Compound 23" (yield 21%) was synthesized using the same method as for the synthesis of "Compound 17" in Synthesis Example 17, except that intermediate "I-23-1" was used instead of intermediate "I-17-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=920(M+H) + 1 H NMR (300 MHz, CDCl 3 ) δ=8.42(s,2H), 8.15(brs,2H), 7.78(brs,2H), 7.68-7.61(m,2H), 7.58-7.54(m,2H), 7.46-7.32(m,10H), 0.72(s,18H)
[0194] Synthesis Example 23: Synthesis of Compound 24 TIFF0007594622000085.tif42152
[0195] 1) Synthesis of intermediate "I-24-1" Intermediate "I-24-1" (yield 70%) was synthesized using the same method as that for intermediate "I-22-1" in Synthesis Example 21, except that intermediate "I-11-3" was used instead of intermediate "I-4-3". The produced compound was confirmed by LC-MS. LC-MS m / z=593(M+H) +
[0196] 2) Synthesis of "Compound 24" "Compound 24" (yield 25%) was synthesized using the same method as for the synthesis of "Compound 22" in Synthesis Example 21, except that intermediate "I-24-1" was used instead of intermediate "I-22-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=786(M+H) + 1 H NMR (300 MHz, CDCl 3 ) δ=8.82(s,2H), 7.93-7.77(m,4H), 7.69-7.64(m,2H), 7.43-7.34(m,2H), 7.31-7.21(m,10H), 7.15-7.10(m,2H), 0.67(s,12H)
[0197] Synthesis Example 24: Synthesis of Compound 25 TIFF0007594622000086.tif52152
[0198] 1) Synthesis of intermediate "I-25-1" Instead of P-SM, P-SM3 (custom compound, HANCHEM CO., www.hanchem.co.kr) was used, and the same method as the synthesis method of intermediate "I-23-1" in Synthesis Example 22 was used to synthesize intermediate "I-25-1" (yield 83%). The produced compound was confirmed by LC-MS. LC-MS m / z=709(M+H) +
[0199] 2) Synthesis of "Compound 25" "Compound 25" (yield 36%) was synthesized using the same method as for the synthesis of "Compound 23" in Synthesis Example 22, except that intermediate "I-25-1" was used instead of intermediate "I-23-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=902(M+H) + 1 H NMR (300 MHz, CDCl 3 ) δ=8.41(s,2H), 8.11(d,2H), 8.00-7.97(m,2H), 7.85-7.82(m,2H), 7.53-7.38(m,4H), 7.37-7.32(m,4H), 7.28-7.22(m,2H), 0.72(s,18H)
[0200] <Synthesis Example 25: Synthesis of Compound 26> TIFF0007594622000087.tif55152
[0201] 1) Synthesis of intermediate "I-26-1" Intermediate "I-26-1" (yield 75%) was synthesized using the same method as that for intermediate "I-25-1" in Synthesis Example 24, except that 2-bromo-5-(trimethylsilyl)pyridine was used instead of intermediate "I-15-3". The produced compound was confirmed by LC-MS. LC-MS m / z=617(M+H) +
[0202] 2) Synthesis of "Compound 26" "Compound 26" (yield 30%) was synthesized using the same method as for the synthesis of "Compound 25" in Synthesis Example 24, except that intermediate "I-26-1" was used instead of intermediate "I-25-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=810(M+H) + 1 H NMR (300 MHz, CDCl 3 ) δ=8.75(brs,2H), 8.08(d,2H), 7.94-7.90(m,2H), 7.84(d,2H), 7.70-7.64(m ,2H), 7.55-7.51(m,4H), 7.38-7.35(m,2H), 7.28-7.24(m,4H), 0.42(s,18H)
[0203] <Synthesis Example 26: Synthesis of Compound 27> TIFF0007594622000088.tif62163
[0204] 1) Synthesis of intermediate "I-27-1" Instead of intermediate "I-15-3", 1-bromo-4-(trimethylsilyl)isoquinoline (custom compound, HANCHEM CO., www.hanchem.co.kr) was used, and intermediate "I-27-1" (yield 52%) was synthesized using the same method as the synthesis method of intermediate "I-25-1" in Synthesis Example 24. The produced compound was confirmed by LC-MS. LC-MS m / z=717(M+H) +
[0205] 2) Synthesis of "Compound 27" "Compound 27" (yield 8%) was synthesized using the same method as for the synthesis of "Compound 25" in Synthesis Example 24, except that intermediate "I-27-1" was used instead of intermediate "I-25-1". The produced compound was confirmed by LC-MS. LC-MS m / z=909(M) +
[0206] <Synthesis Example 27: Synthesis of Compound 28> TIFF0007594622000089.tif101170
[0207] 1) Synthesis of intermediate "I-28-3" Intermediate "I-28-3" (yield 75%) was synthesized using the same method as that for intermediate "I-5-3" in Synthesis Example 5, except that 2,5-dibromo-4-phenylpyridine was used instead of 2,5-dibromopyridine. The produced compound was confirmed by LC-MS. LC-MS m / z=306(M+H) +
[0208] 2) Synthesis of intermediate "I-28-2" Intermediate "I-28-2" (yield 70%) was synthesized using the same method as for synthesizing intermediate "I-5-2" in Synthesis Example 5, except that intermediate "I-28-3" was used instead of intermediate "I-5-3". The produced compound was confirmed by LC-MS. LC-MS m / z=382(M+H) +
[0209] 3) Synthesis of intermediate "I-28-1" Intermediate "I-28-2" was used instead of intermediate "I-5-2" and 2-amino-biphenyl was used instead of 2,4,6-trimethylaniline, but the same method as for synthesizing intermediate "I-5-1" in Synthesis Example 5 was used to synthesize intermediate "I-28-1" (yield 60%). The produced compound was confirmed by LC-MS. LC-MS m / z=772(M+H) +
[0210] 4) Synthesis of "Compound 28" At 25° C., 2.8 g (3.6 mmol) of intermediate “I-28-1” and 100 ml of benzonitrile were added to a reactor. Here, PtCl 2 (NCPh) 2 After adding 1.7 g (3.6 mmol), the mixture was heated to 130° C. for 16 hours. After the reaction was completed, the mixture was concentrated under reduced pressure and purified by column chromatography to obtain 0.9 g (0.9 mmol, yield 26%) of “Compound 28”. The produced compound was confirmed by LCMS. LC-MS m / z=965(M+H) +
[0211] <Synthesis Example 28: Synthesis of Compound 29> TIFF0007594622000090.tif104144
[0212] 1) Synthesis of intermediate "I-29-2" Intermediate "I-29-2" (yield 70%) was synthesized using the same method as that for intermediate "I-3-2" in Synthesis Example 1, except that (5-bromo-[1,1'-biphenyl]-3-yl)boronic acid was used instead of 3-bromophenylboronic acid. The produced compound was confirmed by LC-MS. LC-MS m / z=382(M+H) +
[0213] 2) Synthesis of intermediate "I-29-1" Intermediate "I-29-2" was used instead of intermediate "I-3-2" and 2-amino-biphenyl was used instead of 2,4,6-trimethylaniline, but the same method as for synthesizing intermediate "I-3-1" in Synthesis Example 1 was used to synthesize intermediate "I-29-1" (yield 75%). The produced compound was confirmed by LC-MS. LC-MS m / z=772(M+H) +
[0214] 3) Synthesis of "Compound 29" "Compound 29" (yield 25%) was synthesized using the same method as for the synthesis of "Compound 28" in Synthesis Example 27, except that intermediate "I-29-1" was used instead of intermediate "I-28-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=965(M+H) + 1 H NMR (300 MHz, CD 2 Cl 2 ) δ=9.05(s,2H), 8.07(s,4H), 7.68-7.65(m,1H), 7.64-7.62(m,4H), 7.51-7. 48(m,4H), 7.42-7.31(m,9H), 7.13-7.11(m,3H), 6.65(s,2H), 0.48(s,18H)
[0215] <Synthesis Example 29: Synthesis of Compound 30> TIFF0007594622000091.tif55144
[0216] 1) Synthesis of intermediate "I-30-1" Intermediate "I-30-1" (yield 70%) was synthesized using the same method as that for intermediate "I-29-1" in Synthesis Example 28, except that 4-(trimethylsilyl)naphthalene-1-amine was used instead of 2,4,6-trimethylaniline. The produced compound was confirmed by LC-MS. LC-MS m / z=818(M+H) +
[0217] 2) Synthesis of "Compound 30" "Compound 30" (yield 17%) was synthesized using the same method as for the synthesis of "Compound 28" in Synthesis Example 27, except that intermediate "I-30-1" was used instead of intermediate "I-28-1". The produced compound was confirmed by LCMS. LC-MS m / z=1011 (M+H) +
[0218] Synthesis Example 30: Synthesis of Compound 31 TIFF0007594622000092.tif58144
[0219] 1) Synthesis of intermediate "I-31-1" Intermediate "I-31-1" (yield 75%) was synthesized using the same method as that for intermediate "I-29-1" in Synthesis Example 28, except that 4-isobutylnaphthalene-1-amine was used instead of 2,4,6-trimethylaniline. The produced compound was confirmed by LC-MS. LC-MS m / z=802(M+H) +
[0220] 2) Synthesis of "Compound 31" Compound 31 (yield 15%) was synthesized using the same method as for synthesis of Compound 28 in Synthesis Example 27, except that intermediate I-31-1 was used instead of intermediate I-28-1. The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=995(M+H) + 1 H NMR (300 MHz, CD 2 Cl 2 ) δ=9.04(s,2H), 8.52(brs,1H), 8.36-8.34(m,3H), 7.75-7.69(m,8H), 7.49-7.41(m,8H) , 7.38-7.36(m,2H), 7.29(brs,1H), 6.84(s,1H), 2.86(d,2H), 1.86(q,1H), 0.91(d,6H)
[0221] Synthesis Example 31: Synthesis of Compound 32 TIFF0007594622000093.tif55167
[0222] 1) Synthesis of intermediate "I-32-1" Intermediate "I-32-1" (yield 50%) was synthesized using the same method as that for intermediate "I-29-1" in Synthesis Example 29, except that 2-(2-bromodibenzo[b,d]furan-4-yl)-5-(trimethylsilyl)pyridine was used instead of intermediate "I-29-2" and [4,4'-bipyridine]-3-amine was used instead of 2,4,6-trimethylaniline. The produced compound was confirmed by LC-MS. LC-MS m / z=802(M+H) +
[0223] 2) Synthesis of "Compound 32" "Compound 32" (yield 13%) was synthesized using the same method as for the synthesis of "Compound 28" in Synthesis Example 27, except that intermediate "I-32-1" was used instead of intermediate "I-28-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=995(M+H) + 1 H NMR (300 MHz, CD 2 Cl 2) δ=9.18(s,2H), 8.92(d,2H), 8.65(d,1H), 8.42(s,2H), 8.23(s,1H), 8.01-7 .97(m,3H), 7.80-7.77(m,3H), 7.61(d,2H), 7.54(d,2H), 7.39-7.31(m,4H)
[0224] Synthesis Example 32: Synthesis of Compound 33 TIFF0007594622000094.tif99167
[0225] 1) Synthesis of intermediate "I-33-4" To a reactor were added 9.1 g (25.3 mmol) of 1,3-dibromo-5-iodobenzene, 200 ml of 1,4-dioxane, and 100 ml of distilled water. Here, 5.2 g (25.3 mmol) of 2,6-diisopropylphenylboronic acid, Pd(PPh 3 ) 4 1.5g (1.3mmol) and Ba(OH) 2 After adding 7.8 g (45.5 mmol), the mixture was heated at 80° C. for 18 hours. After the reaction was completed, the mixture was concentrated under reduced pressure, dissolved in 200 ml of dichloromethane, and filtered through diatomaceous earth. The obtained organic layer was dried over magnesium sulfate, distilled under reduced pressure, and purified by liquid chromatography to obtain 8.1 g (20.5 mmol, yield 81%) of intermediate "I-33-4". The produced compound was confirmed by LC-MS. LC-MS m / z=394(M+H) +
[0226] 2) Synthesis of intermediate "I-33-3" 6.0 g (15.1 mmol) of the intermediate "I-33-4" was dissolved in 150 ml of diethyl ether, and then 6.6 ml of n-BuLi (2.5 M solution in hexane) was slowly added at -78°C and stirred for about 1 hour. Thereafter, tri-n-butyltin chloride was slowly added dropwise and the mixture was stirred for about 2 hours. After 2 hours, the temperature was gradually raised to room temperature and the mixture was stirred for about 18 hours. After the reaction was completed, 80 ml of distilled water and 100 ml of ethyl acetate were added for extraction, and the organic layer was dried over magnesium sulfate and distilled under reduced pressure to obtain intermediate "I-33-3". The intermediate "I-33-3" obtained therefrom was used in the next reaction without further purification.
[0227] 3) Synthesis of intermediate "I-33-2" To a reactor, 11.8 g (19.5 mmol) of the intermediate "I-33-3" and 4.5 g (19.5 mmol) of 2-bromo-5-(trimethylsilyl)pyridine were added, and then 150 ml of toluene was added. Here, Pd(PPh 3 ) 4 After adding 1.0 g (1.0 mmol) and 2.3 g (40.0 mmol) of KF, the mixture was heated at 120° C. for 12 hours. After the reaction was complete, the mixture was diluted with 100 ml of ethyl acetate and saturated NH 4 Extraction was performed with aqueous Cl. The obtained organic layer was dried over magnesium sulfate, distilled under reduced pressure, and purified by liquid chromatography to obtain 6.2 g (13.3 mmol, yield 68%) of intermediate "I-33-2". The produced compound was confirmed by LC-MS. LC-MS m / z=466(M+H) +
[0228] 4) Synthesis of intermediate "I-33-1" Intermediate "I-33-2" was used instead of intermediate "I-29-2", and 2-amino-biphenyl was used instead of 2,4,6-trimethylaniline. The same method as for synthesizing intermediate "I-29-1" in Synthesis Example 28 was used to synthesize intermediate "I-33-1" (yield 65%). The produced compound was confirmed by LC-MS. LC-MS m / z=940(M+H) +
[0229] 5) Synthesis of "Compound 33" "Compound 33" (yield 30%) was synthesized using the same method as for the synthesis of "Compound 28" in Synthesis Example 27, except that intermediate "I-33-1" was used instead of intermediate "I-28-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=1133(M+H) + 1 H NMR (300 MHz, CD 2 Cl 2 ) δ=8.66(s,2H), 7.75(d,2H), 7.61(brs,2H), 7.45-7.39(m,3H), 7.32-7.24(m,12H), 7.14- 7.09(m,7H), 6.84-6.83(m,2H), 2.68(brs,4H), 1.06(d,12H), 0.94(d,12H), 0.30(s,18H)
[0230] Synthesis Example 33: Synthesis of Compound 34 TIFF0007594622000095.tif100159
[0231] 1) Synthesis of intermediate "I-34-4" Intermediate "I-34-4" was synthesized using the same method as that for intermediate "I-33-4" in Synthesis Example 33, except that 3,5-di-tert-butylphenylboronic acid was used instead of 2,6-diisopropylphenylboronic acid.
[0232] 2) Synthesis of intermediate "I-34-3" Intermediate "I-34-3" was synthesized using the same method as for the synthesis of intermediate "I-33-3" in Synthesis Example 33, except that intermediate "I-34-4" was used instead of intermediate "I-33-4".
[0233] 3) Synthesis of intermediate "I-34-2" Intermediate "I-34-2" was synthesized using the same method as for intermediate "I-33-2" in Synthesis Example 33, except that intermediate "I-34-3" was used instead of intermediate "I-33-3".
[0234] 4) Synthesis of intermediate "I-34-1" Intermediate "I-34-1" was synthesized using the same method as that for intermediate "I-29-1" in Synthesis Example 29, except that intermediate "I-34-2" was used instead of intermediate "I-29-2" and 2-amino-biphenyl was used instead of 2,4,6-trimethylaniline.
[0235] 5) Synthesis of "Compound 34" Compound 34 (yield 25%) was synthesized using the same method as in Synthesis Example 27 for compound 28, except that intermediate I-34-1 was used instead of intermediate I-28-1. The produced compound was confirmed by LCMS. LC-MS m / z=1189(M+H) +
[0236] Synthesis Example 34: Synthesis of Compound 35 TIFF0007594622000096.tif51162
[0237] 1) Synthesis of intermediate "I-35-1" Intermediate "I-35-1" (yield 70%) was synthesized using the same method as that for intermediate "I-8-1" in Synthesis Example 8, except that dibenzo[b,d]furan-1-amine was used instead of 3-amino-biphenyl. The produced compound was confirmed by LC-MS. LC-MS m / z=634(M+H) +
[0238] 2) Synthesis of "Compound 35" "Compound 35" (yield 30%) was synthesized using the same method as for the synthesis of "Compound 8" in Synthesis Example 8, except that intermediate "I-35-1" was used instead of intermediate "I-8-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=827(M+H) + 1 H NMR (300 MHz, CDCl 3 ) δ=8.76(brs,2H), 7.98(d,1H), 7.83-7.79(m,4H), 7.70-7.68(m,2H), 7.56-7.50(m,3H), 7.34-7.22(m,6H), 6.98(brs,1H), 0.28(s,18H)
[0239] Synthesis Example 35: Synthesis of Compound 36 TIFF0007594622000097.tif108168
[0240] 1) Synthesis of intermediate "I-36-3" Intermediate "I-36-3" (yield 70%) was synthesized using the same method as that for intermediate "I-2-3" in Synthesis Example 3, except that 1-chloro-1-methylsilane was used instead of chlorotrimethylsilane. The produced compound was confirmed by LC-MS. LC-MS m / z=242(M+H) +
[0241] 2) Synthesis of intermediate "I-36-2" Intermediate "I-36-2" (yield 80%) was synthesized using the same method as for synthesizing intermediate "I-2-2" in Synthesis Example 3, except that intermediate "I-36-3" was used instead of intermediate "I-2-3". The produced compound was confirmed by LC-MS. LC-MS m / z=318(M+H) +
[0242] 3) Synthesis of intermediate "I-36-1" Intermediate "I-36-1" (yield 62%) was synthesized using the same method as for synthesizing intermediate "I-2-1" in Synthesis Example 3, except that intermediate "I-36-2" was used instead of intermediate "I-2-2". The produced compound was confirmed by LC-MS. LC-MS m / z=610(M+H) +
[0243] 4) Synthesis of "Compound 36" "Compound 36" (yield 25%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-36-1" was used instead of intermediate "I-2-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=803(M+H) +
[0244] Synthesis Example 36: Synthesis of Compound 37 TIFF0007594622000098.tif109170
[0245] 1) Synthesis of intermediate "I-37-2" Intermediate "I-37-2" (yield 75%) was synthesized using the same method as that for intermediate "I-2-2" in Synthesis Example 3, except that (3-bromo-5-(9H-carbazol-9-yl)phenyl)boronic acid was used instead of intermediate "I-2-3". The produced compound was confirmed by LC-MS. LC-MS m / z=471(M+H) +
[0246] 2) Synthesis of intermediate "I-37-1" Intermediate "I-37-1" (yield 55%) was synthesized using the same method as for synthesizing intermediate "I-2-1" in Synthesis Example 3, except that intermediate "I-37-2" was used instead of intermediate "I-2-2". The produced compound was confirmed by LC-MS. LC-MS m / z=950(M+H) +
[0247] 3) Synthesis of "Compound 37" "Compound 37" (yield 20%) was synthesized using the same method as for synthesizing "Compound 3" in Synthesis Example 1, except that intermediate "I-37-1" was used instead of intermediate "I-2-1". The compounds produced were analyzed by LCMS and 1 Confirmed by 1 H NMR. LC-MS m / z=1143(M+H) +
[0248] Example 1 An ITO / Ag / ITO (70 Å / 1,000 Å / 70 Å) substrate (anode) was cut to a size of 50 mm × 50 mm × 0.5 mm, ultrasonically cleaned for 5 minutes using isopropyl alcohol and pure water, respectively, and then cleaned by exposure to ultraviolet light and ozone for 30 minutes, and the substrate was then placed in a vacuum deposition apparatus. 2-TNATA was vacuum-deposited on the top of the substrate to a thickness of 600 Å to form a hole-injection layer, and then 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (hereinafter referred to as NPB) was vacuum-deposited on the top of the hole-injection layer to a thickness of 1,000 Å to form a hole-transport layer. On the hole transport layer, CBP (host) and “Compound 17” (dopant) were co-deposited in a weight ratio of 91:9 to form a 250 Å-thick light-emitting layer. A hole-blocking layer was formed on the top of the light-emitting layer by vacuum deposition of BCP to a thickness of 50 Å. An electron-transporting layer was formed on the top of the hole-blocking layer by deposition of Alq3 to a thickness of 350 Å. An electron-injecting layer was formed on the top of the electron-transporting layer by deposition of LiF to a thickness of 10 Å. Mg and Ag were co-deposited on the electron injection layer in a weight ratio of 90:10 to form a cathode with a thickness of 120 Å, thereby preparing an organic light emitting device. TIFF0007594622000099.tif98149
[0249] Example 2 An organic light emitting device was manufactured in the same manner as in Example 1, except that "Compound 24" was used instead of "Compound 17" when forming the light emitting layer. Example 3 An organic light emitting device was manufactured using the same method as in Example 1, except that "Compound 25" was used instead of "Compound 17" when forming the light emitting layer.
[0250] Example 4 An ITO / Ag / ITO (70 Å / 1,000 Å / 70 Å) substrate (anode) was cut to a size of 50 mm × 50 mm × 0.5 mm, ultrasonically cleaned for 5 minutes using isopropyl alcohol and pure water, respectively, and then cleaned by exposure to ultraviolet light and ozone for 30 minutes, and the substrate was then placed in a vacuum deposition apparatus. 2-TNATA was vacuum-deposited on the top of the substrate to a thickness of 600 Å to form a hole-injection layer, and then 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl (NPB) was vacuum-deposited on the top of the hole-injection layer to a thickness of 1,350 Å to form a hole-transport layer. On the hole transport layer, CBP (host) and “Compound 3” (dopant) were co-deposited in a weight ratio of 94:6 to form a 400 Å-thick light-emitting layer. On the light-emitting layer, BCP was vacuum-deposited to a thickness of 50 Å to form a hole-blocking layer. On the hole blocking layer, Alq3 was deposited to a thickness of 350 Å to form an electron transport layer, and on the electron transport layer, LiF was deposited to a thickness of 10 Å to form an electron injection layer. Mg and Ag were co-deposited on the electron injection layer in a weight ratio of 90:10 to form a cathode with a thickness of 120 Å, thereby preparing an organic light emitting device.
[0251] Example 5 An organic light emitting device was manufactured in the same manner as in Example 4, except that "Compound 7" was used instead of "Compound 3" when forming the light emitting layer. Example 6 An organic light emitting device was manufactured in the same manner as in Example 4, except that "Compound 11" was used instead of "Compound 3" when forming the light emitting layer. Example 7 An organic light emitting device was manufactured in the same manner as in Example 4, except that "Compound 13" was used instead of "Compound 3" when forming the light emitting layer. Example 8 An organic light emitting device was manufactured in the same manner as in Example 4, except that "Compound 28" was used instead of "Compound 3" when forming the light emitting layer. Example 9 An organic light emitting device was manufactured in the same manner as in Example 4, except that "Compound 29" was used instead of "Compound 3" when forming the light emitting layer.
[0252] Comparative Example 1 An organic light emitting device was manufactured in the same manner as in Example 1, except that the compound A shown below was used instead of "compound 17" when forming the light emitting layer. TIFF0007594622000100.tif46128
[0253] Comparative Example 2 An organic light emitting device was manufactured in the same manner as in Example 1, except that the compound B shown below was used instead of "compound 17" when forming the light emitting layer. TIFF0007594622000101.tif46128
[0254] Comparative Example 3 An organic light emitting device was manufactured in the same manner as in Example 4, except that the compound C shown below was used instead of "compound 3" when forming the light emitting layer. TIFF0007594622000102.tif46128
[0255] Comparative Example 4 An organic light emitting device was manufactured in the same manner as in Example 4, except that Compound D shown below was used instead of "Compound 3" when forming the light emitting layer. TIFF0007594622000103.tif37128
[0256] Comparative Example 5 An organic light emitting device was manufactured in the same manner as in Example 4, except that the compound E shown below was used instead of "compound 3" when forming the light emitting layer. TIFF0007594622000104.tif47128
[0257] <Evaluation Example 1: Evaluation of the characteristics of organic light-emitting devices> The organic light-emitting devices manufactured in Examples 1 to 9 and Comparative Examples 1 to 5 were measured for driving voltage, current density, luminance, efficiency, emitted light, CIE color coordinates, and lifetime (LT 9 7) were evaluated, and the results are shown in Table 1 below. LT 97 indicates the lifespan, and LT 97 means the time it takes for the luminance to decrease to 97% of the initial luminance. [Table 1]
[0258] As shown in Table 1, the organic light emitting devices according to Examples 1 to 3 had a driving voltage lower by about 0.5 to 1.2 V and exhibited excellent IVL characteristics with improved efficiency and life span, as compared to the organic light emitting devices according to Comparative Examples 1 and 2. Moreover, the organic light-emitting devices according to Examples 1 to 3 had improved luminance compared to the organic light-emitting devices according to Comparative Examples 1 and 2. In particular, the organic light emitting devices of Examples 4 to 9 exhibited excellent IVL characteristics with significantly improved efficiency and lifetime compared to the organic light emitting devices of Comparative Examples 3 to 5, and were found to be excellent in improving luminance and lifetime.
[0259] Specifically, in the case of Example 1, an organometallic compound represented by Chemical Formula 1 was used as a green phosphorescent dopant, and it was found that the driving voltage was improved by 1.2 V or more, the efficiency was improved by 110% or more, and the lifetime was improved by 150% compared to Comparative Example 1. Also, in the case of Example 3, compared to Comparative Example 2, it was found that the driving voltage was improved by 0.5 V or more, the efficiency was improved to 120%, and the life span was improved to 120%. In the cases of Examples 4 to 9, the organometallic compound represented by Chemical Formula 1 was used as a red phosphorescent dopant, and it was found that the driving voltage was improved by about 2.0 V, the efficiency was improved to 140%, and the lifetime was improved to more than 1,000% compared to Comparative Example 3.
[0260] The present invention is not limited to the above-described embodiment (example), and can be modified in various ways without departing from the technical scope of the present invention. [Industrial Applicability]
[0261] The organometallic compound according to the present invention and the organic light-emitting device including the same can be suitably used in, for example, technical fields related to light emission. [Explanation of symbols]
[0262] 10 Organic light-emitting device 11 1st electrode 15 Organic layer 19 2nd electrode
Claims
1. An organometallic compound represented by the following chemical formula 1. 【Chemistry 1】 In the above Chemical Formula 1, M is Pt; A 1 ~A 4 are, independently of each other, C 5 -C 20 Carbocyclic groups and C 1 -C 20 heterocyclic groups, The above A 1 and A 2 are each independently selected from the group consisting of a phenyl group, a naphthyl group, and a dibenzofuranyl group; The above A 3 and A 4 at least one of is selected from the group consisting of a pyridinyl group, a pyrimidinyl group, and an isoquinolinyl group; X 1 ~X 2 is a carbon atom (C), and X 3 and X 4 is N, B 1 ~B 4 is a single bond, Y 1 and Y 3 is a single bond, Y 2 is a divalent linking group, The divalent linking group is represented by any one of *-O-*' and the following chemical formulas (8-1), (9-2) to (9-5), (9-8), (9-14), (9-16), (9-17), (9-52), (9-64), and (9-67), 【Chemistry (8-1)(9-2)-(9-5)(9-8)】 【Chemistry (9-14) (9-16) (9-17)】 【Chemistry (9-52)】 【Chemistry (9-64) (9-67)】 In the chemical formulas (8-1), (9-2) to (9-5), (9-8), (9-14), (9-16), (9-17), (9-52), (9-64), and (9-67), R 81 is a dibenzofuranyl group, Ph is a phenyl group; 4-pyr is a 4-pyridinyl group; Z 1 and Z 2 are each independently represented by any one of the following chemical formulas (2-21) to (2-27) and (2-31), 【Chemistry (2-21)-(2-27)】 【Chemistry (2-31)】 In the chemical formulas (2-21) to (2-27) and (2-31), Et is an ethyl group; Ph is a phenyl group; d1 and d2 are 1; R 1 ~R 4 are each independently a hydrogen atom, a methyl group, an iso-butyl group, a phenyl group and a carbazolyl group, and C 3 Or C 4 a phenyl group substituted with at least one alkyl group; with the exception that R 1 and R 2 are the same and are selected from hydrogen, a phenyl group, a carbazolyl group, or a phenyl group substituted with a C 3 or C 4 alkyl group, and R 3 and R 4 are the same and are selected from hydrogen, a methyl group, or an iso-butyl group; b1 to b4 are independently selected from 1, 2, 3 and 4; L 1 is selected from monodentate and bidentate ligands; a1 is selected from 0, 1 and 2; * and *' are bonding sites with adjacent atoms.
2. A first electrode; A second electrode; An organic light-emitting device comprising: an organic layer interposed between the first electrode and the second electrode, the organic layer including a light-emitting layer and at least one organometallic compound according to claim 1 .
3. The organic light-emitting device according to claim 2 , wherein the organometallic compound is contained in the light-emitting layer.
Citation Information
Patent Citations
Silyl-substituted cyclometallized transition metal complex and organic electroluminescent element using the same
JP2006290891A
Iridium complex having excellent solubility and organic el device
JP2006290988A
Organic electroluminescent element
JP2011071452A
Novel silylated metal complexes
JP2014024841A
NOVEL ORGANOMETAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE SAME
JP2014509587A
